Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL50 (3'-hydroxykaempferol, C.i. 75670, Ci-75670, C.I. Natural Red 1, Corvitin, Cyanidenolon 1522, Korvitin, LDN 0052529, LDN-0052529, Lipoflavon, Meletin, NSC 57655, NSC-57655, NSC 9219, NSC-9219, Quercetin, Quercetin (constituent of ginkgo), Quercetine, Quercetol, Quertin, Quertine, Sophoretin, Xanthaurine) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
3-oxoacyl-acyl-carrier protein reductase in Plasmodium falciparum (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4513] [UniProtKB: Q965D6] | ||||||||
ChEMBL | Inhibition of FabG | B | 5.27 | pIC50 | 5400 | nM | IC50 | J Med Chem (2006) 49: 3345-3353 [PMID:16722653] |
Ecto-5'-Nucleotidase/5`-nucleotidase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5957] [GtoPdb: 1232] [UniProtKB: P21589] | ||||||||
ChEMBL | Inhibition of human N-terminal Ecto-5'-nucleotidase | B | 4.34 | pIC50 | 45300 | nM | IC50 | Eur J Med Chem (2023) 247: 115052-115052 [PMID:36599229] |
Ecto-5'-Nucleotidase/5`-nucleotidase in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075214] [GtoPdb: 1232] [UniProtKB: P21588] | ||||||||
GtoPdb | - | - | 7.34 | pKi | 45.3 | nM | Ki | J Med Chem (2010) 53: 2076-86 [PMID:20146483] |
ChEMBL | Inhibition of rat ecto-5'-nucleotidase expressed in Sf9 cells by capillary electrophoresis method | B | 7.34 | pKi | 45.3 | nM | Ki | J Med Chem (2010) 53: 2076-2086 [PMID:20146483] |
acetylcholinesterase (Yt blood group)/Acetylcholinesterase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL220] [GtoPdb: 2465] [UniProtKB: P22303] | ||||||||
ChEMBL | Inhibition of human recombinant AChE by Ellman's method | B | 4.42 | pKi | 38300 | nM | Ki | Eur J Med Chem (2010) 45: 186-192 [PMID:19879672] |
ChEMBL | Inhibition of AChE (unknown origin) | B | 5.54 | pIC50 | 2910 | nM | IC50 | Eur J Med Chem (2021) 221: 113492-113492 [PMID:33984802] |
A1 receptor/Adenosine A1 receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL318] [GtoPdb: 18] [UniProtKB: P25099] | ||||||||
ChEMBL | Displacement of specific [3H]PIA binding from adenosine A1 receptor in rat brain membranes. | B | 5.61 | pKi | 2470 | nM | Ki | J Med Chem (1996) 39: 781-788 [PMID:8576921] |
A2A receptor/Adenosine A2a receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL302] [GtoPdb: 19] [UniProtKB: P30543] | ||||||||
ChEMBL | Affinity at Adenosine A2A receptor in rat striatal membranes by [3H]- CGS 21680 displacement. | B | 5.16 | pKi | 6990 | nM | Ki | J Med Chem (1996) 39: 781-788 [PMID:8576921] |
A3 receptor/Adenosine A3 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL256] [GtoPdb: 21] [UniProtKB: P0DMS8] | ||||||||
ChEMBL | Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells | B | 4.52 | pKi | 30000 | nM | Ki | J Med Chem (1996) 39: 781-788 [PMID:8576921] |
Alcohol sulfotransferase in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3007] [UniProtKB: P15709] | ||||||||
ChEMBL | Inhibition of rat SULT2A1-mediated dehydroepiandrosterone sulfonation incubated for 20 mins | B | 4.47 | pIC50 | 34000 | nM | IC50 | Eur J Med Chem (2021) 213: 113037-113037 [PMID:33257172] |
Aldehyde reductase in Pig (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4049] [UniProtKB: P50578] | ||||||||
ChEMBL | Inhibition of pig ALR1 | B | 4.42 | pIC50 | 38400 | nM | IC50 | Bioorg Med Chem (2009) 17: 1244-1250 [PMID:19121944] |
Aldehyde reductase in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3871] [UniProtKB: P51635] | ||||||||
ChEMBL | In vitro inhibitory activity against aldehyde reductase 1 (ALR1) from rat kidney. | B | 5.63 | pIC50 | 2320 | nM | IC50 | J Med Chem (2003) 46: 1419-1428 [PMID:12672241] |
Aldo-keto reductase family 1 member C21 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075270] [UniProtKB: Q91WR5] | ||||||||
ChEMBL | Inhibition of mouse recombinant AKR1C21 | B | 4.96 | pKi | 11000 | nM | Ki | Bioorg Med Chem (2008) 16: 3245-3254 [PMID:18165015] |
ChEMBL | Inhibition of mouse recombinant AKR1C21 | B | 5.16 | pIC50 | 6900 | nM | IC50 | Bioorg Med Chem (2008) 16: 3245-3254 [PMID:18165015] |
aldo-keto reductase family 1 member B/Aldose reductase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1900] [GtoPdb: 2768] [UniProtKB: P15121] | ||||||||
ChEMBL | Inhibition of human recombinant aldose reductase using DL-glyceraldehyde, HRAR and beta-NADPH incubated for 10 mins by spectrophotometry | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg Med Chem Lett (2014) 24: 4407-4409 [PMID:25152999] |
ChEMBL | Inhibition of aldose reductase by spectrophotometric analysis | B | 5.55 | pIC50 | 2850 | nM | IC50 | Bioorg Med Chem Lett (2011) 21: 1222-1226 [PMID:21256748] |
ChEMBL | Inhibition of human recombinant aldose reductase | B | 5.66 | pIC50 | 2200 | nM | IC50 | Bioorg Med Chem (2008) 16: 3245-3254 [PMID:18165015] |
ChEMBL | Inhibition of human recombinant aldose reductase using D-glyceraldehyde as substrate preincubated for 10 mins before substrate addition measured for every 10 secs for 50 mins by spectrophotometry | B | 5.66 | pIC50 | 2200 | nM | IC50 | Bioorg Med Chem (2012) 20: 1251-1258 [PMID:22261024] |
ChEMBL | Inhibition of cataracted human eye lens aldose reductase | B | 7.83 | pIC50 | 14.8 | nM | IC50 | Bioorg Med Chem (2008) 16: 10085-10090 [PMID:18976928] |
Aldose reductase in Pig (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4559] [UniProtKB: P80276] | ||||||||
ChEMBL | Inhibition of pig lens aldose reductase by spectrophotometry | B | 4.3 | pIC50 | 50100 | nM | IC50 | J Nat Prod (1996) 59: 443-445 [PMID:8699190] |
Aldose reductase in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3081] [UniProtKB: P16116] | ||||||||
ChEMBL | Evaluated for inhibition of Aldose reductase 2 | B | 4.4 | pIC50 | 39900 | nM | IC50 | J Med Chem (1996) 39: 4396-4405 [PMID:8893834] |
ChEMBL | Inhibition of ALR2 (aldose reductase) of bovine lens | B | 4.48 | pIC50 | 32870 | nM | IC50 | J Med Chem (1999) 42: 1881-1893 [PMID:10354396] |
ChEMBL | The compound was tested for Inhibitory effect against ALR1 in bovine kidneys | B | 4.99 | pIC50 | 10340 | nM | IC50 | J Med Chem (1999) 42: 1881-1893 [PMID:10354396] |
ChEMBL | Inhibition of Aldehyde reductase 2 | B | 4.99 | pIC50 | 10300 | nM | IC50 | J Med Chem (1996) 39: 4396-4405 [PMID:8893834] |
ChEMBL | Inhibition of aldose reductase from calf lense by AR assay | B | 5.55 | pIC50 | 2850 | nM | IC50 | Bioorg Med Chem (2010) 18: 3020-3025 [PMID:20395149] |
ChEMBL | Inhibition of bovine lens aldose reductase using DL-glyceraldehyde as substrate assessed as NADPH oxidation measured for 10 mins by spectrophotometric analysis | B | 5.55 | pIC50 | 2850 | nM | IC50 | Bioorg Med Chem (2013) 21: 4301-4310 [PMID:23683835] |
aldo-keto reductase family 1 member B/Aldose reductase in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2622] [GtoPdb: 2768] [UniProtKB: P07943] | ||||||||
ChEMBL | In vitro inhibitory activity against aldose reductase (ALR2) from rat lens extraction. | B | 5.08 | pIC50 | 8320 | nM | IC50 | J Med Chem (2003) 46: 1419-1428 [PMID:12672241] |
ChEMBL | Inhibition of ALR2 in Sprague-Dawley Albino rat lens | B | 5.11 | pIC50 | 7810 | nM | IC50 | J Med Chem (2007) 50: 4917-4927 [PMID:17845019] |
ChEMBL | In vitro inhibitory activity against aldose reductase (ALR2) from rat lens extraction. | B | 5.11 | pIC50 | 7810 | nM | IC50 | J Med Chem (2003) 46: 1419-1428 [PMID:12672241] |
ChEMBL | Inhibitory concentration to aldose reductase (ALR-2) obtained from rat lens | B | 5.11 | pIC50 | 7810 | nM | IC50 | J Med Chem (2001) 44: 4359-4369 [PMID:11728182] |
ChEMBL | In vitro inhibitory activity against Aldose reductase from rat lens | B | 5.11 | pIC50 | 7700 | nM | IC50 | J Med Chem (1991) 34: 3229-3234 [PMID:1956041] |
ChEMBL | Inhibition of rat lens aldose reductase | B | 5.14 | pIC50 | 7210 | nM | IC50 | J Nat Prod (2008) 71: 713-715 [PMID:18298080] |
ChEMBL | Inhibition of ALR1 in Sprague-Dawley Albino rat kidney | B | 5.63 | pIC50 | 2320 | nM | IC50 | J Med Chem (2007) 50: 4917-4927 [PMID:17845019] |
ChEMBL | In vitro inhibitory activity against L-Hexonate Dehydrogenase from rat kidney | B | 6 | pIC50 | 1000 | nM | IC50 | J Med Chem (1991) 34: 3229-3234 [PMID:1956041] |
ALK receptor tyrosine kinase/ALK tyrosine kinase receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4247] [GtoPdb: 1839] [UniProtKB: Q9UM73] | ||||||||
ChEMBL | Inhibition of ALK (unknown origin) | B | 5.48 | pIC50 | 3320 | nM | IC50 | J Nat Prod (2014) 77: 49-56 [PMID:24328302] |
Alpha-glucosidase MAL62 in Saccharomyces cerevisiae (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4357] [UniProtKB: P07265] | ||||||||
ChEMBL | Inhibition of baker's yeast alpha-glucosidase using p-nitrophenyl-alpha-D-glucopyranoside as substrate by spectrophotometry | B | 0.84 | pIC50 | 0.84 | - | logIC50 | Med Chem Res (2012) 21: 3984-3993 |
synuclein alpha/Alpha-synuclein in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6152] [GtoPdb: 3285] [UniProtKB: P37840] | ||||||||
ChEMBL | Inhibition of human alpha-synuclein filament formation expressed in Escherichia coli BL21(DE3) cells incubated for 72 hrs by thioflavin S based fluorescence assay | B | 4.7 | pIC50 | 20000 | nM | IC50 | Eur J Med Chem (2019) 167: 10-36 [PMID:30743095] |
Amyloid-beta A4 protein in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2487] [UniProtKB: P05067] | ||||||||
ChEMBL | Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay | B | 4.82 | pIC50 | 15300 | nM | IC50 | Bioorg Med Chem (2016) 24: 304-313 [PMID:26719209] |
ChEMBL | Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) | B | 5.1 | pIC50 | 7940 | nM | IC50 | Bioorg Med Chem (2017) 25: 1195-1201 [PMID:28043778] |
ChEMBL | Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation incubated for 1 hr by thioflavin-T fluorescence assay | B | 5.62 | pIC50 | 2400 | nM | IC50 | Eur J Med Chem (2018) 152: 570-589 [PMID:29763806] |
ChEMBL | Inhibition of amyloid beta 40 peptide (unknown origin) aggregation incubated for 2 hr by ThT fluorescence based spectrofluorimetric analysis | B | 6.09 | pIC50 | 820 | nM | IC50 | Eur J Med Chem (2023) 250: 115169-115169 [PMID:36753881] |
12S-LOX/Arachidonate 12-lipoxygenase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3687] [GtoPdb: 1387] [UniProtKB: P18054] | ||||||||
ChEMBL | Inhibition of 12-hLO | B | 6.36 | pIC50 | 440 | nM | IC50 | Bioorg Med Chem (2007) 15: 7408-7425 [PMID:17869117] |
15-LOX-1/Arachidonate 15-lipoxygenase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2903] [GtoPdb: 1388] [UniProtKB: P16050] | ||||||||
ChEMBL | Inhibition of 15-hLO1 | B | 5.66 | pIC50 | 2200 | nM | IC50 | Bioorg Med Chem (2007) 15: 7408-7425 [PMID:17869117] |
Arachidonate 15-lipoxygenase in Rabbit (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4358] [UniProtKB: P12530] | ||||||||
ChEMBL | Inhibition of rabbit reticulocytes arachidonate 15-lipoxygenase | B | 4.43 | pIC50 | 37000 | nM | IC50 | Eur J Med Chem (2011) 46: 5237-5257 [PMID:21937153] |
ChEMBL | Inhibition of 15LOX in rabbit reticulocytes by EIA assay | B | 6.37 | pIC50 | 430 | nM | IC50 | J Nat Prod (2007) 70: 859-862 [PMID:17378609] |
15-LOX-2/Arachidonate 15-lipoxygenase, type II in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2457] [GtoPdb: 1389] [UniProtKB: O15296] | ||||||||
ChEMBL | Inhibition of 15-hLO2 | B | 4 | pIC50 | >100000 | nM | IC50 | Bioorg Med Chem (2007) 15: 7408-7425 [PMID:17869117] |
5-LOX/Arachidonate 5-lipoxygenase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL215] [GtoPdb: 1385] [UniProtKB: P09917] | ||||||||
ChEMBL | Inhibition of human PMNL 5-LOX using arachidonic acid as substrate after 5 mins by HPLC method | B | 4.62 | pIC50 | 24000 | nM | IC50 | Bioorg Med Chem (2019) 27: 3745-3759 [PMID:31331653] |
ChEMBL | Inhibition of 5-LOX-mediated LTB4 production in human neutrophils using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition measured after 8 mins by enzyme immunoassay | B | 5.4 | pIC50 | 4000 | nM | IC50 | Eur J Med Chem (2014) 72: 137-145 [PMID:24368208] |
ChEMBL | Inhibition of 5-LOX (unknown origin) by colorimetric analysis | B | 5.48 | pIC50 | 3340 | nM | IC50 | RSC Med Chem (2022) 13: 522-567 [PMID:35694689] |
ChEMBL | Inhibition of 5-LO activity in ionophore A23187 and arachidonic-stimulated human intact PMNL | F | 5.52 | pIC50 | 3000 | nM | IC50 | J Med Chem (2007) 50: 2640-2646 [PMID:17461565] |
ChEMBL | Inhibition of 5-LOX in polymorphonuclear leucocytes (unknown origin) | B | 5.52 | pIC50 | 3000 | nM | IC50 | Eur J Med Chem (2019) 175: 215-233 [PMID:31082765] |
ChEMBL | Inhibition of 5LOX in human PBMC by EIA assay | B | 6.1 | pIC50 | 790 | nM | IC50 | J Nat Prod (2007) 70: 859-862 [PMID:17378609] |
5-LOX/Arachidonate 5-lipoxygenase in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL312] [GtoPdb: 1385] [UniProtKB: P12527] | ||||||||
ChEMBL | In vitro inhibition of LTB4 production was measured in rat blood | F | 5 | pIC50 | 10000 | nM | IC50 | J Med Chem (1991) 34: 1028-1036 [PMID:1848292] |
ChEMBL | In vitro inhibition of 5-lipoxygenase in rat (peritoneal assay) | B | 6.3 | pIC50 | 500 | nM | IC50 | J Med Chem (1990) 33: 2744-2749 [PMID:2213827] |
ChEMBL | Iin vitro inhibition of 5-lipoxygenase activity in rat basophil leukemia type 1(RBL1) cell homogenates, (reduction of [14C]-5-HETE formation) | B | 6.4 | pIC50 | 400 | nM | IC50 | J Med Chem (1990) 33: 2744-2749 [PMID:2213827] |
ChEMBL | In vitro inhibition of 5-lipoxygenase (5-lo) from the 20000 g supernatant of RBI-1 cells | B | 6.52 | pIC50 | 300 | nM | IC50 | J Med Chem (1991) 34: 2158-2165 [PMID:2066989] |
ChEMBL | In vitro inhibitory activity against RBL-1 5-LO | B | 6.52 | pIC50 | 300 | nM | IC50 | J Med Chem (1987) 30: 574-580 [PMID:3820229] |
ChEMBL | In vitro inhibition against 5-lipoxygenase in RBL-1 cells was determined | B | 6.7 | pIC50 | 200 | nM | IC50 | J Med Chem (1993) 36: 3904-3909 [PMID:8254620] |
Arginase in Leishmania amazonensis (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3108635] [UniProtKB: O96394] | ||||||||
ChEMBL | Inhibition of Leishmania amazonensis recombinant arginase expressed in Escherichia coli Rosetta (DE3) pLysS using L-arginine as substrate incubated for 10 mins prior to substrate addition measured after 10 mins by colorimetry | B | 5.4 | pIC50 | 4000 | nM | IC50 | J Nat Prod (2014) 77: 392-396 [PMID:24521209] |
Aryl sulfotransferase in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4886] [UniProtKB: P17988] | ||||||||
ChEMBL | Inhibition of rat liver SULT1A1-mediated oestradiol sulfonation incubated for 20 mins | B | 6.54 | pIC50 | 290 | nM | IC50 | Eur J Med Chem (2021) 213: 113037-113037 [PMID:33257172] |
ABCG2/ATP-binding cassette sub-family G member 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5393] [GtoPdb: 792] [UniProtKB: Q9UNQ0] | ||||||||
ChEMBL | Inhibition of BCRP expressed in MCF-7 MX cells using Hoechst 33342 staining | B | 5.12 | pIC50 | 7600 | nM | IC50 | Bioorg Med Chem (2011) 19: 2090-2102 [PMID:21354800] |
ChEMBL | Inhibition of BCRP expressed in MDCK cells using Hoechst 33342 staining | B | 5.16 | pIC50 | 6900 | nM | IC50 | Bioorg Med Chem (2011) 19: 2090-2102 [PMID:21354800] |
ChEMBL | Activation of ABCG2 (unknown origin) ATPase activity expressed in baculovirus infected high five cell membranes by ascorbic acid/ammonia molybdate reaction-based colorimetric analysis | B | 6.56 | pEC50 | 278 | nM | EC50 | J Med Chem (2017) 60: 4474-4495 [PMID:28471656] |
ChEMBL | Activation of ABCG2 ATPase activity (unknown origin) expressed in baculovirus infected high5 cell membranes after 20 mins by ascorbic acid ammonia molybdate reaction based colorimetric assay | B | 6.56 | pEC50 | 278 | nM | EC50 | Eur J Med Chem (2017) 139: 587-611 [PMID:28841513] |
ChEMBL | Activation of recombinant human ABCG2 ATPase activity expressed in baculovirus infected High five insect cell membranes after 20 mins by ascorbic acid ammonia molybdate reaction-based colorimetric method | B | 7.52 | pEC50 | 30 | nM | EC50 | J Med Chem (2018) 61: 3389-3408 [PMID:29547272] |
beta-catenin-B-cell lymphoma 9 protein complex in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL3885525] [UniProtKB: O00512, P35222] | ||||||||
ChEMBL | Inhibition of beta-catenin (unknown origin) to BCL9-FAM (unknown origin) protein-protein interaction preincubated for 2 hrs followed by BCL9 addition and measured after 2 hrs by fluorescence polarization assay | B | 5 | pIC50 | 10080 | nM | IC50 | Eur J Med Chem (2023) 247: 115075-115075 [PMID:36599228] |
ChEMBL | Inhibition of full length beta-catenin (unknown origin)/FAM labeled BCL9 (350 to 375 residues) (unknown origin) protein-protein interaction by competitive FP assay | B | 5 | pIC50 | 10080 | nM | IC50 | Bioorg Med Chem Lett (2024) 98: 129591-129591 [PMID:38097141] |
ChEMBL | Inhibition of full length beta-catenin (unknown origin) to BCL9-FAM (350 to 375 residues) (unknown origin) protein-protein interaction incubated for 2 hrs by fluorescence polarization assay | B | 5 | pIC50 | 10070 | nM | IC50 | Eur J Med Chem (2023) 247: 115075-115075 [PMID:36599228] |
chymotrypsinogen B1/Beta-chymotrypsin in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4796] [GtoPdb: 3272] [UniProtKB: P17538] | ||||||||
ChEMBL | Inhibitory activity against Chymotrypsinogen from Thermus flavus | B | 4 | pIC50 | 100000 | nM | IC50 | J Med Chem (2003) 46: 1478-1483 [PMID:12672248] |
Beta-lactamase in Enterobacter cloacae (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2725] [UniProtKB: P05364] | ||||||||
ChEMBL | Inhibition of Enterobacter cloacae beta-lactamase incubated for 10 mins followed by nitrocefin substrate challenge and measured for 5 mins by spectrophotometric analysis | B | 4.07 | pIC50 | 85000 | nM | IC50 | ACS Med Chem Lett (2019) 10: 923-928 [PMID:31223449] |
Beta-lactamase AmpC in Escherichia coli (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2026] [UniProtKB: P00811] | ||||||||
ChEMBL | Inhibitory activity against Amp C beta-Lactamase | B | 5.4 | pIC50 | 4000 | nM | IC50 | J Med Chem (2003) 46: 4265-4272 [PMID:13678405] |
ChEMBL | Inhibitory activity against Beta-lactamase from DMSO stock was determined | B | 5.4 | pIC50 | 4000 | nM | IC50 | J Med Chem (2003) 46: 4265-4272 [PMID:13678405] |
ChEMBL | Inhibitory activity against beta-lactamase | B | 5.4 | pIC50 | 4000 | nM | IC50 | J Med Chem (2002) 45: 1712-1722 [PMID:11931626] |
beta-secretase 1/Beta-secretase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4822] [GtoPdb: 2330] [UniProtKB: P56817] | ||||||||
ChEMBL | Noncompetitive inhibition of human recombinant BACE1 after 60 mins by Dixon plot analysis | B | 4.85 | pKi | 14000 | nM | Ki | Bioorg Med Chem Lett (2010) 20: 3211-3215 [PMID:20462757] |
ChEMBL | Inhibition of human recombinant BACE1 after 60 mins by FRET assay | B | 4.97 | pIC50 | 10820 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 3211-3215 [PMID:20462757] |
ChEMBL | Inhibition of human recombinant BACE1 by fluorescence resonance energy transfer (FRET) assay | B | 5.19 | pIC50 | 6500 | nM | IC50 | Bioorg Med Chem (2015) 23: 3126-3134 [PMID:26003344] |
ChEMBL | Inhibition of recombinant human BACE1 using Rh-EVNLDAEFK-Quencher as substrate after 60 mins by FRET assay | B | 5.25 | pIC50 | 5600 | nM | IC50 | Bioorg Med Chem (2017) 25: 3964-3970 [PMID:28576634] |
ChEMBL | Inhibition of BACE1 (unknown origin) | B | 5.27 | pIC50 | 5400 | nM | IC50 | Med Chem Res (2013) 22: 3061-3075 |
ChEMBL | Inhibition of BACE1 (unknown origin) | B | 6.26 | pIC50 | 550 | nM | IC50 | Eur J Med Chem (2021) 221: 113492-113492 [PMID:33984802] |
butyrylcholinesterase/Butyrylcholinesterase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1914] [GtoPdb: 2471] [UniProtKB: P06276] | ||||||||
ChEMBL | Inhibition of human plasma BChE by Ellman's method | B | 4.17 | pKi | 68000 | nM | Ki | Eur J Med Chem (2010) 45: 186-192 [PMID:19879672] |
Calmodulin in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6093] [UniProtKB: P0DP23] | ||||||||
ChEMBL | Inhibition of human recombinant calmodulin assessed as inhibition of calmodulin-sensitive cAMP phosphodiesterase activation after 15 mins by spectrophotometric analysis | B | 4.89 | pIC50 | 12970 | nM | IC50 | Bioorg Med Chem (2011) 19: 542-546 [PMID:21129983] |
calcium/calmodulin-dependent protein kinase II beta subunit/CaM kinase II beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4121] [GtoPdb: 1556] [UniProtKB: Q13554] | ||||||||
ChEMBL | Inhibition of CAMK2 using autocamtide-2 as substrate after 30 mins by PKLight assay | B | 5.52 | pIC50 | 3000 | nM | IC50 | Bioorg Med Chem (2011) 19: 4710-4720 [PMID:21798748] |
carbonic anhydrase 1/Carbonic anhydrase I in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL261] [GtoPdb: 2597] [UniProtKB: P00915] | ||||||||
ChEMBL | Inhibition of human CA1 by stopped-flow CO2 hydration assay | B | 5.57 | pKi | 2680 | nM | Ki | Bioorg Med Chem (2010) 18: 2159-2164 [PMID:20185318] |
carbonic anhydrase 2/Carbonic anhydrase II in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL205] [GtoPdb: 3092] [UniProtKB: P00918] | ||||||||
ChEMBL | Inhibition of human CA2 by stopped-flow CO2 hydration assay | B | 5.6 | pKi | 2540 | nM | Ki | Bioorg Med Chem (2010) 18: 2159-2164 [PMID:20185318] |
Carbonic anhydrase III in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2885] [UniProtKB: P07451] | ||||||||
ChEMBL | Inhibition of human CA3 by stopped-flow CO2 hydration assay | B | 5.09 | pKi | 8100 | nM | Ki | Bioorg Med Chem (2010) 18: 2159-2164 [PMID:20185318] |
carbonic anhydrase 4/Carbonic anhydrase IV in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3729] [GtoPdb: 2599] [UniProtKB: P22748] | ||||||||
ChEMBL | Inhibition of human CA4 by stopped-flow CO2 hydration assay | B | 5.1 | pKi | 7890 | nM | Ki | Bioorg Med Chem (2010) 18: 2159-2164 [PMID:20185318] |
carbonic anhydrase 9/Carbonic anhydrase IX in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3594] [GtoPdb: 3055] [UniProtKB: Q16790] | ||||||||
ChEMBL | Inhibition of human CA9 by stopped-flow CO2 hydration assay | B | 5.15 | pKi | 7000 | nM | Ki | Bioorg Med Chem (2010) 18: 2159-2164 [PMID:20185318] |
carbonic anhydrase 5A/Carbonic anhydrase VA in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4789] [GtoPdb: 3093] [UniProtKB: P35218] | ||||||||
ChEMBL | Inhibition of human CA5A by stopped-flow CO2 hydration assay | B | 5.17 | pKi | 6810 | nM | Ki | Bioorg Med Chem (2010) 18: 2159-2164 [PMID:20185318] |
Carbonic anhydrase VB in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3969] [UniProtKB: Q9Y2D0] | ||||||||
ChEMBL | Inhibition of human CA5B by stopped-flow CO2 hydration assay | B | 4.92 | pKi | 11900 | nM | Ki | Bioorg Med Chem (2010) 18: 2159-2164 [PMID:20185318] |
Carbonic anhydrase VI in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3025] [UniProtKB: P23280] | ||||||||
ChEMBL | Inhibition of human CA6 by stopped-flow CO2 hydration assay | B | 5.21 | pKi | 6170 | nM | Ki | Bioorg Med Chem (2010) 18: 2159-2164 [PMID:20185318] |
carbonic anhydrase 7/Carbonic anhydrase VII in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2326] [GtoPdb: 2749] [UniProtKB: P43166] | ||||||||
ChEMBL | Inhibition of human CA7 by stopped-flow CO2 hydration assay | B | 5.32 | pKi | 4840 | nM | Ki | Bioorg Med Chem (2010) 18: 2159-2164 [PMID:20185318] |
carbonic anhydrase 12/Carbonic anhydrase XII in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3242] [GtoPdb: 2747] [UniProtKB: O43570] | ||||||||
ChEMBL | Inhibition of human CA12 by stopped-flow CO2 hydration assay | B | 5.03 | pKi | 9390 | nM | Ki | Bioorg Med Chem (2010) 18: 2159-2164 [PMID:20185318] |
carbonic anhydrase 13/Carbonic anhydrase XIII in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2186] [GtoPdb: 2748] [UniProtKB: Q9D6N1] | ||||||||
ChEMBL | Inhibition of mouse CA13 by stopped-flow CO2 hydration assay | B | 5.04 | pKi | 9030 | nM | Ki | Bioorg Med Chem (2010) 18: 2159-2164 [PMID:20185318] |
carbonic anhydrase 14/Carbonic anhydrase XIV in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3510] [GtoPdb: 2598] [UniProtKB: Q9ULX7] | ||||||||
ChEMBL | Inhibition of human CA14 by stopped-flow CO2 hydration assay | B | 5.27 | pKi | 5410 | nM | Ki | Bioorg Med Chem (2010) 18: 2159-2164 [PMID:20185318] |
casein kinase 2, alpha 1 polypeptide subunit/casein kinase 2, beta polypeptide subunit/Casein kinase 2 in Rat (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL3988629] [GtoPdb: 1549, 1551] [UniProtKB: P19139, P67874] | ||||||||
ChEMBL | Inhibition of rat liver CK2 phosphorylation using RRRADDSDDDDD as substrate in presence of [32p]-ATP | B | 6.26 | pIC50 | 550 | nM | IC50 | J Med Chem (2023) 66: 2257-2281 [PMID:36745746] |
casein kinase 2, alpha prime polypeptide subunit/casein kinase 2, beta polypeptide subunit/casein kinase 2, alpha 1 polypeptide subunit/Casein kinase II in Human (target type: PROTEIN COMPLEX GROUP) [ChEMBL: CHEMBL2095191] [GtoPdb: 1550, 1551, 1549] [UniProtKB: P19784, P67870, P68400] | ||||||||
ChEMBL | Inhibition of CK2 using RRRADDSDDDDD as substrate after 30 mins by PKLight assay | B | 5.25 | pIC50 | 5600 | nM | IC50 | Bioorg Med Chem (2011) 19: 4710-4720 [PMID:21798748] |
ChEMBL | Inhibition of recombinant human CK2 expressed in Escherichia coli using RRRADDSDDDDD as substrate after 10 mins | B | 6 | pIC50 | <1000 | nM | IC50 | J Med Chem (2015) 58: 7400-7408 [PMID:26322379] |
ChEMBL | Inhibition of recombinant human CK2 activity assessed as [gamma-32P]ATP incorporation into substrate peptide after 20 mins in presence of 50 uM ATP | B | 6.26 | pIC50 | 550 | nM | IC50 | Eur J Med Chem (2011) 46: 870-876 [PMID:21276643] |
ChEMBL | Inhibition of CK2 (unknown origin) | B | 6.26 | pIC50 | 550 | nM | IC50 | Bioorg Med Chem (2013) 21: 6681-6689 [PMID:24011954] |
casein kinase 2, alpha 1 polypeptide subunit/Casein kinase II alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3629] [GtoPdb: 1549] [UniProtKB: P68400] | ||||||||
ChEMBL | Inhibitory constant against Zea mays CK2alpha | B | 5.93 | pKi | 1180 | nM | Ki | Biochem J (2003) 374: 639-646 [PMID:12816539] |
ChEMBL | Inhibition of CK2alpha (unknown origin) | B | 5.93 | pKi | 1180 | nM | Ki | Eur J Med Chem (2019) 181: 111581-111581 [PMID:31400711] |
Catenin beta-1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5866] [UniProtKB: P35222] | ||||||||
ChEMBL | Binding affinity to full length His-tagged beta-catenin (1 to 781 residues) (unknown origin) expressed in Escherichia coli DE3 by surface plasmon resonance assay | B | 5.25 | pKd | 5580 | nM | Kd | Eur J Med Chem (2023) 247: 115075-115075 [PMID:36599228] |
ChEMBL | Binding affinity to full length beta-catenin (unknown origin) assessed as dissociation constant by SPR analysis | B | 5.3 | pKd | 4990 | nM | Kd | Bioorg Med Chem Lett (2024) 98: 129591-129591 [PMID:38097141] |
CCR4/C-C chemokine receptor type 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2414] [GtoPdb: 61] [UniProtKB: P51679] | ||||||||
ChEMBL | Inhibition of CCL22-stimulated CCR4 in human HTLA cells pre-incubated for 20 mins with Tween-80-treated compound solution measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay | B | 4 | pIC50 | >100000 | nM | IC50 | J Med Chem (2013) 56: 2406-2414 [PMID:23437772] |
ChEMBL | Inhibition of CCL22-stimulated CCR4 in human HTLA cells pre-incubated for 20 mins with centrifuged compound solution measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay | B | 4 | pIC50 | 100000 | nM | IC50 | J Med Chem (2013) 56: 2406-2414 [PMID:23437772] |
ChEMBL | Inhibition of CCL22-stimulated CCR4 in human HTLA cells pre-incubated for 20 mins with Tween-80-treated compound solution measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay | B | 4.5 | pIC50 | >31622.78 | nM | IC50 | J Med Chem (2013) 56: 2406-2414 [PMID:23437772] |
ChEMBL | Inhibition of CCL22-stimulated CCR4 in human HTLA cells pre-incubated for 20 mins with centrifuged compound solution measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay | B | 4.5 | pIC50 | >31622.78 | nM | IC50 | J Med Chem (2013) 56: 2406-2414 [PMID:23437772] |
ChEMBL | Inhibition of CCL22-stimulated CCR4 in human HTLA cells pre-incubated for 20 mins measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay | B | 4.99 | pIC50 | 10200 | nM | IC50 | J Med Chem (2013) 56: 2406-2414 [PMID:23437772] |
ChEMBL | Inhibition of CCL22-stimulated CCR4 in human HTLA cells pre-incubated for 20 mins measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay | B | 5 | pIC50 | 10000 | nM | IC50 | J Med Chem (2013) 56: 2406-2414 [PMID:23437772] |
cyclin dependent kinase 5/Cell division protein kinase 5 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5901] [GtoPdb: 1977] [UniProtKB: Q03114] | ||||||||
ChEMBL | Inhibition of rat fetal brain CDK5 assessed as phosphorylated histone H1 levels by immuno-precipitation | B | 4.2 | pEC50 | 63400 | nM | EC50 | J Nat Prod (2004) 67: 416-420 [PMID:15043421] |
chymotrypsin C/Chymotrypsin C in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2386] [GtoPdb: 2341] [UniProtKB: Q99895] | ||||||||
ChEMBL | Inhibitory activity against chymotrypsinogen | B | 4 | pIC50 | 100000 | nM | IC50 | J Med Chem (2002) 45: 1712-1722 [PMID:11931626] |
cyclin dependent kinase 1/Cyclin-dependent kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL308] [GtoPdb: 1961] [UniProtKB: P06493] | ||||||||
ChEMBL | Inhibition of CDK1 | B | 6.35 | pIC50 | 450 | nM | IC50 | Eur J Med Chem (2010) 45: 4316-4330 [PMID:20638755] |
cyclin dependent kinase 1/Cyclin-dependent kinase 1/cyclin B in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2094127] [GtoPdb: 1961] [UniProtKB: O95067, P06493, P14635, Q8WWL7] | ||||||||
ChEMBL | Inhibition of cyclin-dependent kinase 1/cyclinB | B | 4.12 | pIC50 | 75000 | nM | IC50 | J Med Chem (2005) 48: 737-743 [PMID:15689157] |
cyclin dependent kinase 1/Cyclin-dependent kinase 1/cyclin B1 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL1907602] [GtoPdb: 1961] [UniProtKB: P06493, P14635] | ||||||||
ChEMBL | Inhibition of Cyclin-dependent kinase 1-cyclin B1 | B | 4.7 | pIC50 | 20000 | nM | IC50 | Bioorg Med Chem Lett (2000) 10: 1037-1041 [PMID:10843211] |
ChEMBL | Inhibition of Cdk1/cyclin B | B | 4.7 | pIC50 | >20000 | nM | IC50 | Bioorg Med Chem (2008) 16: 7128-7133 [PMID:18639462] |
cyclin dependent kinase 2/Cyclin-dependent kinase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL301] [GtoPdb: 1973] [UniProtKB: P24941] | ||||||||
ChEMBL | Inhibition of CDK2 | B | 4.4 | pIC50 | 40000 | nM | IC50 | Bioorg Med Chem Lett (2007) 17: 1284-1287 [PMID:17178224] |
cyclin dependent kinase 4/Cyclin-dependent kinase 4/cyclin D1 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL1907601] [GtoPdb: 1976] [UniProtKB: P11802, P24385] | ||||||||
ChEMBL | Inhibitory activity against cyclin-dependent kinase 4-cyclin D1 | B | 4.21 | pIC50 | 61000 | nM | IC50 | Bioorg Med Chem Lett (2000) 10: 1037-1041 [PMID:10843211] |
cyclin dependent kinase 5/Cyclin-dependent kinase 5/CDK5 activator 1 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL1907600] [GtoPdb: 1977] [UniProtKB: Q00535, Q15078] | ||||||||
ChEMBL | Inhibition of Cyclin-dependent kinase 5-p25nck5a | B | 4.64 | pIC50 | 23000 | nM | IC50 | J Med Chem (2005) 48: 737-743 [PMID:15689157] |
cyclin dependent kinase 6/Cyclin-dependent kinase 6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2508] [GtoPdb: 1978] [UniProtKB: Q00534] | ||||||||
ChEMBL | Inhibition of human cyclin-dependent kinase 6 complex with a virus-encoded cyclin from herpesvirus saimiri (Vcyclin) | B | 4.6 | pIC50 | 25000 | nM | IC50 | J Med Chem (2005) 48: 737-743 [PMID:15689157] |
ChEMBL | Inhibition of Homo sapiens (human) cyclin-dependent kinase 6 | B | 4.6 | pIC50 | 25000 | nM | IC50 | Med Chem Res (2010) 19: 817-835 |
COX-2 /Cyclooxygenase-2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL230] [GtoPdb: 1376] [UniProtKB: P35354] | ||||||||
ChEMBL | Inhibition of human recombinant COX2 expressed in insect Sf21 cells by EIA assay | B | 4.54 | pIC50 | 28600 | nM | IC50 | J Nat Prod (2007) 70: 859-862 [PMID:17378609] |
CFTR/Cystic fibrosis transmembrane conductance regulator in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4051] [GtoPdb: 707] [UniProtKB: P13569] | ||||||||
ChEMBL | Binding affinity to sensorchip-immobilized human His-tagged CFTR F508 deletion mutant by surface plasmon resonance analysis | B | 4.59 | pKd | 25600 | nM | Kd | Eur J Med Chem (2021) 213: 113186-113186 [PMID:33472120] |
CYP19A1/Cytochrome P450 19A1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1978] [GtoPdb: 1362] [UniProtKB: P11511] | ||||||||
ChEMBL | Inhibition of aromatase (unknown origin) | B | 4.92 | pIC50 | 12000 | nM | IC50 | Eur J Med Chem (2015) 102: 375-386 [PMID:26301554] |
ChEMBL | Inhibition of human placental microsome CYP19 | B | 7.92 | pIC50 | 12 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 3050-3064 [PMID:20413308] |
CYP1A1/Cytochrome P450 1A1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2231] [GtoPdb: 1318] [UniProtKB: P04798] | ||||||||
ChEMBL | Inhibition of recombinant human CYP1A1 expressed in yeast microsomal membranes by fluorescence assay | B | 4.7 | pIC50 | >20000 | nM | IC50 | Bioorg Med Chem Lett (2017) 27: 5400-5403 [PMID:29150398] |
ChEMBL | Inhibition of human CYP1A1 transfected in HEK293 cells assessed as cell toxicity | B | 5 | pIC50 | 9900 | nM | IC50 | Bioorg Med Chem Lett (2017) 27: 5400-5403 [PMID:29150398] |
ChEMBL | Inhibition of human CYP1A1 transfected in HEK293 cells assessed as protection against CYP1A1 mediated B[a]P toxicity by measuring B[a]P EC50 at 20 uM by MTT assay (Rvb =1.2+/- 0.3 uM) | B | 5.06 | pEC50 | 8800 | nM | EC50 | Bioorg Med Chem Lett (2017) 27: 5400-5403 [PMID:29150398] |
CYP1B1/Cytochrome P450 1B1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4878] [GtoPdb: 1320] [UniProtKB: Q16678] | ||||||||
ChEMBL | Inhibition of CYP1B1 (unknown origin) | B | 7.64 | pKi | 23 | nM | Ki | Eur J Med Chem (2017) 135: 296-306 [PMID:28458135] |
GtoPdb | - | - | 7.64 | pKi | 23 | nM | Ki | Eur J Med Chem (2017) 135: 296-306 [PMID:28458135] |
ChEMBL | Inhibition of human CYP1B1 expressed in HEK293 cells by fluorescence assay | B | 5.66 | pIC50 | 2200 | nM | IC50 | Bioorg Med Chem Lett (2017) 27: 5400-5403 [PMID:29150398] |
ChEMBL | Inhibition of human CYP1B1 expressed in MDA-MB-468 cells assessed as cell toxicity | B | 5.66 | pIC50 | 2200 | nM | IC50 | Bioorg Med Chem Lett (2017) 27: 5400-5403 [PMID:29150398] |
ChEMBL | Inhibition of human CYP1B1 expressed in yeast microsomal membranes using 7-ethoxyresorufin as substrate by fluorescence assay | B | 6 | pIC50 | 1000 | nM | IC50 | Bioorg Med Chem Lett (2017) 27: 5400-5403 [PMID:29150398] |
ChEMBL | Inhibition of human CYP1B1 by EROD assay | B | 7.11 | pIC50 | 77 | nM | IC50 | Bioorg Med Chem (2010) 18: 6310-6315 [PMID:20696580] |
ChEMBL | Inhibition of CYP1B1 (unknown origin) | B | 7.11 | pIC50 | 77 | nM | IC50 | Eur J Med Chem (2017) 130: 320-327 [PMID:28259840] |
ChEMBL | Inhibition of human CYP1B1 expressed in MDA-MB-468 cells assessed as potentiation of cisplatin-induced cytotoxicity by measuring cisplatin EC50 at 6.6 uM (Rvb = 6.70+/- 0.7 uM) | B | 5.96 | pEC50 | 1100 | nM | EC50 | Bioorg Med Chem Lett (2017) 27: 5400-5403 [PMID:29150398] |
CYP2C8/Cytochrome P450 2C8 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3721] [GtoPdb: 1325] [UniProtKB: P10632] | ||||||||
ChEMBL | Fluorescent High Throughput P450 Assay: The interaction of SC12 with cytochrome P450 enzymes was tested using Fluorescent High Throughput P450 assays (Gentest); The IC50s of the compounds was calculated on isoenzymes (CYP1A2, CYP2C9, CYP2C19, CYP2C8, CYP2B6, CYP2D6, CYP2E1, CYP3A4 and CYP3A5). Inhibition of the P450 isoforms was measured in specific assays using specific substrates that become fluorescent upon CYP metabolism. Compounds, dissolved in ACN (acetonitrile) (CYP2E1, CYP2C8, CYP2B6, CYP3A5) or DMSO (all remaining isoforms), were tested in duplicate (n=2) in concentration-response curves (eight concentrations) in a 96-well plate containing incubation/NADPH regenerating buffer. Specific isoenzymes and substrates were added and incubated at 37° C. Reactions were terminated at different times, depending on the assays, and plates read on a Fluoroskan Ascent at the appropriate emission/excitation wavelengths. Concentration-response curves performed in duplicate for known inhibitors for each isoenzyme were tested in ever | B | 5.46 | pIC50 | 3500 | nM | IC50 | US-9173935-B2. Phospholipid drug analogs (2015) |
ChEMBL | Fluorescent High Throughput P450 Assays: The interaction of SC12 with cytochrome P450 enzymes was tested using Fluorescent High Throughput P450 assays (Gentest); The IC50s of the compounds was calculated on isoenzymes (CYP1A2, CYP2C9, CYP2C19, CYP2C8, CYP2B6, CYP2D6, CYP2E1, CYP3A4 and CYP3A5).Materials and Methods: Inhibition of the P450 isoforms was measured in specific assays using specific substrates that become fluorescent upon CYP metabolism. Compounds, dissolved in ACN (acetonitrile) (CYP2E1, CYP2C8, CYP2B6, CYP3A5) or DMSO (all remaining isoforms), were tested in duplicate (n=2) in concentration-response curves (eight concentrations) in a 96-well plate containing incubation/NADPH regenerating buffer. Specific isoenzymes and substrates were added and incubated at 37° C. Reactions were terminated at different times, depending on the assays, and plates read on a Fluoroskan Ascent at the appropriate emission/excitation wavelengths. | B | 5.46 | pIC50 | 3500 | nM | IC50 | US-9180183-B2. Phospholipid drug analogs (2015) |
Cytosol aminopeptidase in Pig (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5624] [UniProtKB: P28839] | ||||||||
ChEMBL | Inhibition of pig kidney cytosolic Leucyl aminopeptidase | B | 4.46 | pIC50 | 34300 | nM | IC50 | J Nat Prod (1995) 58: 823-829 [PMID:7673925] |
D-alanine--D-alanine ligase in Helicobacter pylori (strain HPAG1) (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2366488] [UniProtKB: Q1CTD3] | ||||||||
ChEMBL | Binding affinity to Helicobacter pylori Ddl by surface plasmon resonance biosensor technology | B | 4.89 | pKd | 12900 | nM | Kd | Med Chem Res (2013) 22: 2139-2150 |
ChEMBL | Competitive inhibition of Helicobacter pylori Ddl using ATP as substrate | B | 5.37 | pKi | 4300 | nM | Ki | Med Chem Res (2013) 22: 2139-2150 |
ChEMBL | Competitive inhibition of Helicobacter pylori Ddl using ATP as substrate | B | 4.31 | pIC50 | 48500 | nM | IC50 | Med Chem Res (2013) 22: 2139-2150 |
D-alanylalanine synthetase in Escherichia coli (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1956] [UniProtKB: P07862] | ||||||||
ChEMBL | Competitive inhibition of Escherichia coli DdlB using ATP as substrate | B | 4.7 | pIC50 | 19900 | nM | IC50 | Med Chem Res (2013) 22: 2139-2150 |
death associated protein kinase 1/Death-associated protein kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2558] [GtoPdb: 2002] [UniProtKB: P53355] | ||||||||
ChEMBL | Displacement of ANS from DAPK1 catalytic domain (1 to 285) (unknown origin) after 30 mins by fluorescence assay | B | 5.05 | pIC50 | 8900 | nM | IC50 | J Med Chem (2015) 58: 7400-7408 [PMID:26322379] |
dipeptidyl peptidase 4/Dipeptidyl peptidase IV in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL284] [GtoPdb: 1612] [UniProtKB: P27487] | ||||||||
ChEMBL | Inhibition of human DPP4 using H-Gly-Pro-AMC peptide substrate assessed as increase in fluorescence for 20 mins by fluorimetric assay | B | 4.49 | pIC50 | 32730 | nM | IC50 | Medchemcomm (2011) 2: 471-477 |
ChEMBL | Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 4 secs followed by substrate addition and measured after 30 mins by luminescence assay | B | 5.53 | pIC50 | 2920 | nM | IC50 | Eur J Med Chem (2018) 151: 145-157 [PMID:29609120] |
DNA polymerase eta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5542] [UniProtKB: Q9Y253] | ||||||||
ChEMBL | Inhibition of C-terminal 6xHis-tagged human DNA polymerase eta (1 to 511 residues) expressed in Escherichia coli BL21 DE3 using 5'-IRD700-GCAGGTCGACTCCAAAG-3' primer/ 5'-TCGGTACCGGGTTAGCCTTTGGAGTCGACCTGC-3' template as DNA substrate incubated for 60 mins in presence of Mg2+ by bromophenol blue staining based assay | B | 4.8 | pIC50 | 15800 | nM | IC50 | Eur J Med Chem (2023) 248: 115044-115044 [PMID:36621139] |
D4 receptor/Dopamine D4 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL219] [GtoPdb: 217] [UniProtKB: P21917] | ||||||||
ChEMBL | Binding affinity to dopamine D4 receptor | B | 5.11 | pKi | 7846 | nM | Ki | J Nat Prod (2010) 73: 1015-1021 [PMID:20408551] |
mitogen-activated protein kinase kinase 1/Dual specificity mitogen-activated protein kinase kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3587] [GtoPdb: 2062] [UniProtKB: Q02750] | ||||||||
ChEMBL | Inhibition of wild type MEK1 (unknown origin) | B | 5 | pIC50 | >10000 | nM | IC50 | J Nat Prod (2014) 77: 49-56 [PMID:24328302] |
ELAV-like protein 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1250379] [UniProtKB: Q15717] | ||||||||
ChEMBL | Inhibition of ELAV1 (unknown origin)-ARE TNFalpha complex formation after 20 mins by liquid scintillation counting method | B | 5.85 | pIC50 | 1400 | nM | IC50 | J Med Chem (2017) 60: 8257-8267 [PMID:28587461] |
ELAV-like protein 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4105924] [UniProtKB: Q14576] | ||||||||
ChEMBL | Inhibition of ELAV3 (unknown origin)-artificial ARE complex formation after 30 mins in the presence of biotin-labeled RNA probe by chemiluminescence nucleic acid detection method | B | 5.74 | pIC50 | 1800 | nM | IC50 | J Med Chem (2017) 60: 8257-8267 [PMID:28587461] |
Enoyl-[acyl-carrier-protein] reductase in Escherichia coli (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1857] [UniProtKB: P0AEK4] | ||||||||
ChEMBL | Inhibition of Escherichia coli ENR | B | 4.7 | pIC50 | 20000 | nM | IC50 | J Med Chem (2007) 50: 765-775 [PMID:17263522] |
Enoyl-acyl-carrier protein reductase in Plasmodium falciparum (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4150] [UniProtKB: Q965D5] | ||||||||
ChEMBL | Inhibition of Plasmodium falciparum ENR using NADH substrate | B | 5.96 | pKi | 1090 | nM | Ki | J Med Chem (2007) 50: 765-775 [PMID:17263522] |
ChEMBL | Inhibition of Plasmodium falciparum ENR using crotonyl-CoA substrate | B | 6.33 | pKi | 473 | nM | Ki | J Med Chem (2007) 50: 765-775 [PMID:17263522] |
ChEMBL | Inhibition of Plasmodium falciparum ENR in presence of triclosan | B | 7.66 | pKi | 22 | nM | Ki | J Med Chem (2007) 50: 765-775 [PMID:17263522] |
ChEMBL | Inhibition of Plasmodium falciparum ENR | B | 5.6 | pIC50 | 2500 | nM | IC50 | J Med Chem (2007) 50: 765-775 [PMID:17263522] |
ChEMBL | Inhibition of FabI | B | 5.82 | pIC50 | 1500 | nM | IC50 | J Med Chem (2006) 49: 3345-3353 [PMID:16722653] |
ChEMBL | Inhibition of Plasmodium falciparum FabI | B | 5.82 | pIC50 | 1500 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 4779-4781 [PMID:20637612] |
epidermal growth factor receptor/Epidermal growth factor receptor erbB1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL203] [GtoPdb: 1797] [UniProtKB: P00533] | ||||||||
ChEMBL | Inhibition of recombinant human EGFR using peptide as substrate by fluorimetric analysis | B | 4.83 | pIC50 | 14900 | nM | IC50 | Eur J Med Chem (2018) 150: 491-505 [PMID:29549836] |
ChEMBL | Inhibition of EGFR | B | 6.05 | pIC50 | 900 | nM | IC50 | Eur J Med Chem (2009) 44: 1982-1988 [PMID:19041163] |
epoxide hydrolase 2/Epoxide hydratase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2409] [GtoPdb: 2970] [UniProtKB: P34913] | ||||||||
ChEMBL | Inhibition of sEH (unknown origin) assessed as substrate PHOME hydrolysis after 1 hr by fluorescence method | B | 4.47 | pIC50 | 33540 | nM | IC50 | Bioorg Med Chem Lett (2014) 24: 1895-1900 [PMID:24679441] |
hydroxysteroid 17-beta dehydrogenase 2/Estradiol 17-beta-dehydrogenase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2789] [GtoPdb: 3094] [UniProtKB: P37059] | ||||||||
ChEMBL | Inhibition of human recombinant 17beta-HSD2 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol | B | 5.81 | pIC50 | 1540 | nM | IC50 | J Med Chem (2008) 51: 4188-4199 [PMID:18533708] |
ChEMBL | Inhibition of human 17beta-HSD2 expressed in HEK293 cell lysates incubated for 10 mins using [2,4,6,7-3H]-estradiol and NAD+ by scintillation counting method | B | 5.81 | pIC50 | 1540 | nM | IC50 | J Nat Prod (2017) 80: 965-974 [PMID:28319389] |
Fatty acid synthase in Plasmodium falciparum (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4512] [UniProtKB: Q965D7] | ||||||||
ChEMBL | Inhibition of FabZ | B | 5.82 | pIC50 | 1500 | nM | IC50 | J Med Chem (2006) 49: 3345-3353 [PMID:16722653] |
protein tyrosine kinase 2/Focal adhesion kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2695] [GtoPdb: 2180] [UniProtKB: Q05397] | ||||||||
ChEMBL | Inhibition of FAK (unknown origin) | B | 5.92 | pIC50 | 1200 | nM | IC50 | J Nat Prod (2014) 77: 49-56 [PMID:24328302] |
Glutathione reductase in Saccharomyces cerevisiae S288c (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4119] [UniProtKB: P41921] | ||||||||
ChEMBL | In vitro inhibitory activity against glutathione reductase (GR) from bakers yeast | B | 4.31 | pIC50 | 48800 | nM | IC50 | J Med Chem (2003) 46: 1419-1428 [PMID:12672241] |
glycogen synthase kinase 3 beta/Glycogen synthase kinase-3 beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL262] [GtoPdb: 2030] [UniProtKB: P49841] | ||||||||
ChEMBL | Inhibition of Homo sapiens (human) recombinant GSK3beta after 30 min by Kinase-Glo assay | B | 5.7 | pIC50 | 2000 | nM | IC50 | Med Chem Res (2013) 22: 3061-3075 |
Glyoxalase I in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2424] [UniProtKB: Q04760] | ||||||||
ChEMBL | Inhibition constant of compound against binding of Yeast Glyoxalase I | B | 4.82 | pKi | 15135.61 | nM | Ki | J Med Chem (1988) 31: 1396-1406 [PMID:3290487] |
ChEMBL | Inhibition of human recombinant His-tagged Glyoxalase 1 expressed in Sf21-Baculovirus system | B | 5.49 | pIC50 | 3200 | nM | IC50 | Bioorg Med Chem (2008) 16: 3969-3975 [PMID:18258440] |
GPR35/G-protein coupled receptor 35 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1293267] [GtoPdb: 102] [UniProtKB: Q9HC97] | ||||||||
ChEMBL | Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins | B | 4.81 | pIC50 | 15400 | nM | IC50 | ACS Med Chem Lett (2012) 3: 165-169 [PMID:24900447] |
ChEMBL | Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay | F | 5.1 | pEC50 | 8020 | nM | EC50 | ACS Med Chem Lett (2012) 3: 165-169 [PMID:24900447] |
ChEMBL | Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay | F | 5.23 | pEC50 | 5930 | nM | EC50 | ACS Med Chem Lett (2012) 3: 165-169 [PMID:24900447] |
Heat shock factor protein 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5869] [UniProtKB: Q00613] | ||||||||
ChEMBL | Inhibition of HSF1 (unknown origin) | B | 4.3 | pIC50 | >50000 | nM | IC50 | Bioorg Med Chem Lett (2015) 25: 3409-3414 [PMID:26164188] |
MET proto-oncogene, receptor tyrosine kinase/Hepatocyte growth factor receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3717] [GtoPdb: 1815] [UniProtKB: P08581] | ||||||||
ChEMBL | Inhibition of wild type MET (unknown origin) | B | 6.24 | pIC50 | 580 | nM | IC50 | J Nat Prod (2014) 77: 49-56 [PMID:24328302] |
histone deacetylase 6/Histone deacetylase 6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1865] [GtoPdb: 2618] [UniProtKB: Q9UBN7] | ||||||||
ChEMBL | Determination of IC50 values for inhibition of enzymatic assay of human HDAC6 with custom peptide substrate | B | 6.09 | pIC50 | 816.6 | nM | IC50 | HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators |
Human immunodeficiency virus type 1 integrase in Human immunodeficiency virus 1 (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3471] [UniProtKB: Q7ZJM1] | ||||||||
ChEMBL | IC50 was measured as concentration required to inhibit 50% of HIV-integrase cleavage | B | 4.63 | pIC50 | 23600 | nM | IC50 | J Med Chem (1995) 38: 890-897 [PMID:7699704] |
ChEMBL | Inhibition of recombinant HIV-1 integrase 3'-processing activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis | B | 4.7 | pIC50 | >20000 | nM | IC50 | Bioorg Med Chem (2014) 22: 3146-3158 [PMID:24794743] |
ChEMBL | IC50 was measured as concentration required to inhibit 50% of HIV-integrase integration | B | 4.87 | pIC50 | 13600 | nM | IC50 | J Med Chem (1995) 38: 890-897 [PMID:7699704] |
ChEMBL | Inhibition of recombinant HIV-1 integrase strand transfer activity using 32P 5' end-labeled linear 21'mer as substrate preincubated for 30 mins prior to substrate challenge by phosphorimaging analysis | B | 5.1 | pIC50 | 8000 | nM | IC50 | Bioorg Med Chem (2014) 22: 3146-3158 [PMID:24794743] |
ChEMBL | Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay | B | 6.22 | pIC50 | 600 | nM | IC50 | Bioorg Med Chem (2014) 22: 3146-3158 [PMID:24794743] |
Hypoxia-inducible factor 1-alpha inhibitor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5909] [UniProtKB: Q9NWT6] | ||||||||
ChEMBL | Inhibition of human recombinant FIH1 | B | 4.99 | pIC50 | 10200 | nM | IC50 | Bioorg Med Chem (2009) 17: 7769-7774 [PMID:19822432] |
Inositol hexakisphosphate kinase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4523488] [UniProtKB: Q9UHH9] | ||||||||
ChEMBL | Inhibition of human IP6K2 using insP6 as substrate preincubated for 15 mins followed by substrate and measured after 30 mins by TR-FRET assay | B | 6.15 | pIC50 | 700 | nM | IC50 | J Med Chem (2019) 62: 1443-1454 [PMID:30624931] |
Inositol polyphosphate multikinase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4523401] [UniProtKB: Q8NFU5] | ||||||||
ChEMBL | Inhibition of human IPMK using insP3 as substrate preincubated for 15 mins followed by substrate and measured after 30 mins by TR-FRET assay | B | 5.64 | pIC50 | 2300 | nM | IC50 | J Med Chem (2019) 62: 1443-1454 [PMID:30624931] |
Insulin-like growth factor I receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1957] [GtoPdb: 1801] [UniProtKB: P08069] | ||||||||
ChEMBL | Inhibition of IGF1R (unknown origin) | B | 6.52 | pIC50 | 300 | nM | IC50 | J Nat Prod (2014) 77: 49-56 [PMID:24328302] |
CXCR1/Interleukin-8 receptor A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4029] [GtoPdb: 68] [UniProtKB: P25024] | ||||||||
ChEMBL | Inhibition of CX3CL1-stimulated CX3CR1 in human HTLA cells pre-incubated for 20 mins with Tween-80-treated compound solution measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay | B | 4 | pIC50 | >100000 | nM | IC50 | J Med Chem (2013) 56: 2406-2414 [PMID:23437772] |
ChEMBL | Inhibition of CX3CL1-stimulated CX3CR1 in human HTLA cells pre-incubated for 20 mins with Tween-80-treated compound solution measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay | B | 4.49 | pIC50 | >32000 | nM | IC50 | J Med Chem (2013) 56: 2406-2414 [PMID:23437772] |
ChEMBL | Inhibition of CX3CL1-stimulated CX3CR1 in human HTLA cells pre-incubated for 20 mins measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay | B | 5.3 | pIC50 | 5011.87 | nM | IC50 | J Med Chem (2013) 56: 2406-2414 [PMID:23437772] |
ChEMBL | Inhibition of CX3CL1-stimulated CX3CR1 in human HTLA cells pre-incubated for 20 mins measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay | B | 5.35 | pIC50 | 4500 | nM | IC50 | J Med Chem (2013) 56: 2406-2414 [PMID:23437772] |
Lactoperoxidase in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2295561] [UniProtKB: P80025] | ||||||||
ChEMBL | Inhibition of bovine milk LPO assessed as reduction in NaOSCN production in presence of H2O2/NaSCN after 5 mins | B | 5.21 | pIC50 | 6100 | nM | IC50 | J Med Chem (2017) 60: 6563-6586 [PMID:28671460] |
elastase, neutrophil expressed/Leukocyte elastase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL248] [GtoPdb: 2358] [UniProtKB: P08246] | ||||||||
ChEMBL | Noncompetitive inhibition of human neutrophil elastase using varying levels of MeOSuc-AAPV-pNA as substrate measured after 30 mins by double-reciprocal Lineweaver-Burk plot analysis | B | 4.92 | pKi | 11900 | nM | Ki | J Nat Prod (2017) 80: 2659-2665 [PMID:28968119] |
ChEMBL | Inhibition of human neutrophil elastase using MeOSuc-AAPV-pNA as substrate measured after 30 mins by spectrometric method | B | 4.84 | pIC50 | 14300 | nM | IC50 | J Nat Prod (2017) 80: 2659-2665 [PMID:28968119] |
Liver glycogen phosphorylase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2568] [UniProtKB: P06737] | ||||||||
ChEMBL | Inhibition of glycogen phosphorylase a (unknown origin) | B | 5.32 | pIC50 | 4800 | nM | IC50 | Bioorg Med Chem (2014) 22: 4810-4825 [PMID:25092521] |
CD38/Lymphocyte differentiation antigen CD38 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4660] [GtoPdb: 2766] [UniProtKB: P28907] | ||||||||
ChEMBL | Inhibition of human CD38 using 20 uM 1, N6-etheno NAD+ as substrate by continuous fluorimetric method | B | 4.42 | pIC50 | 37900 | nM | IC50 | Bioorg Med Chem Lett (2011) 21: 3939-3942 [PMID:21641214] |
lysine demethylase 1A/Lysine-specific histone demethylase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6136] [GtoPdb: 2669] [UniProtKB: O60341] | ||||||||
ChEMBL | Inhibition of LSD1 (unknown origin) by fluorescence assay | B | 5.9 | pIC50 | 1260 | nM | IC50 | Bioorg Med Chem (2019) 27: 370-374 [PMID:30552007] |
Malate dehydrogenase in Thermus thermophilus (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4255] [UniProtKB: P10584] | ||||||||
ChEMBL | Inhibitory activity against malate dehydrogenase (MDH) from Thermus flavus | B | 5.22 | pIC50 | 6000 | nM | IC50 | J Med Chem (2003) 46: 1478-1483 [PMID:12672248] |
maltase-glucoamylase/Maltase-glucoamylase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2074] [GtoPdb: 2627] [UniProtKB: O43451] | ||||||||
ChEMBL | Inhibition of alpha-glucosidase (unknown origin) using p-nitrophenyl-alpha-D-glucopyranoside as substrate incubated for 50 mins by microplate reader analysis | B | 4.97 | pIC50 | 10800 | nM | IC50 | Bioorg Med Chem Lett (2021) 53: 128422-128422 [PMID:34710624] |
MMP1/Matrix metalloproteinase-1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL332] [GtoPdb: 1628] [UniProtKB: P03956] | ||||||||
ChEMBL | Binding affinity to human MMP-1 catalytic domain (100 to 269 residues) expressed in Escherichia coli BL21 Star (DE3) by SPR analysis | B | 4.29 | pKd | 51800 | nM | Kd | Bioorg Med Chem (2022) 68: 116854-116854 [PMID:35667156] |
MMP12/Matrix metalloproteinase 12 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4393] [GtoPdb: 1636] [UniProtKB: P39900] | ||||||||
ChEMBL | Inhibition of human recombinant MMP12 catalytic domain incubated for 20 mins by fluorimetric assay | B | 4.99 | pIC50 | 10230 | nM | IC50 | Bioorg Med Chem (2012) 20: 4164-4171 [PMID:22658537] |
MMP13/Matrix metalloproteinase 13 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL280] [GtoPdb: 1637] [UniProtKB: P45452] | ||||||||
ChEMBL | Inhibition of human recombinant MMP13 catalytic domain incubated for 20 mins by fluorimetric assay | B | 5.07 | pIC50 | 8460 | nM | IC50 | Bioorg Med Chem (2012) 20: 4164-4171 [PMID:22658537] |
MMP2/Matrix metalloproteinase-2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL333] [GtoPdb: 1629] [UniProtKB: P08253] | ||||||||
ChEMBL | Inhibition of human recombinant MMP2 catalytic domain incubated for 20 mins by fluorimetric assay | B | 5.18 | pIC50 | 6680 | nM | IC50 | Bioorg Med Chem (2012) 20: 4164-4171 [PMID:22658537] |
MMP3/Matrix metalloproteinase 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL283] [GtoPdb: 1630] [UniProtKB: P08254] | ||||||||
ChEMBL | Inhibition of human recombinant MMP3 catalytic domain incubated for 20 mins by fluorimetric assay | B | 5.25 | pIC50 | 5570 | nM | IC50 | Bioorg Med Chem (2012) 20: 4164-4171 [PMID:22658537] |
MMP9/Matrix metalloproteinase 9 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL321] [GtoPdb: 1633] [UniProtKB: P14780] | ||||||||
ChEMBL | Inhibition of human recombinant MMP9 catalytic domain incubated for 20 mins by fluorimetric assay | B | 5.79 | pIC50 | 1610 | nM | IC50 | Bioorg Med Chem (2012) 20: 4164-4171 [PMID:22658537] |
ChEMBL | Inhibition of MMP9 (unknown origin) by colorimetric assay | B | 6.76 | pIC50 | 173.8 | nM | IC50 | Eur J Med Chem (2021) 222: 113558-113558 [PMID:34116327] |
methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit/METTL3/METTL14 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL4106140] [GtoPdb: 3181] [UniProtKB: Q86U44, Q9HCE5] | ||||||||
ChEMBL | Inhibition of METTL3/METTL14 (unknown origin) using RNA 5'-GGACUGGACUGGACU-3' as substrate incubated for 2 hrs by LC-MS/MS analysis | B | 5.56 | pIC50 | 2730 | nM | IC50 | J Med Chem (2023) 66: 1654-1677 [PMID:36692498] |
Monoamine oxidase A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1951] [GtoPdb: 2489] [UniProtKB: P21397] | ||||||||
ChEMBL | Inhibition of MAO-A (unknown origin) incubated for 60 mins by fluorometric spectrophotometry analysis | B | 4.93 | pIC50 | 11640 | nM | IC50 | Eur J Med Chem (2018) 145: 445-497 [PMID:29335210] |
ChEMBL | Inhibition of MAO-A (unknown origin) incubated for 60 mins by fluorometric spectrophotometry analysis | B | 4.96 | pIC50 | 10890 | nM | IC50 | Eur J Med Chem (2018) 145: 445-497 [PMID:29335210] |
ChEMBL | Inhibition of human MAOA | B | 5.55 | pIC50 | 2800 | nM | IC50 | Bioorg Med Chem (2010) 18: 1273-1279 [PMID:20045650] |
ChEMBL | Inhibition of MAO-A (unknown origin) | B | 5.55 | pIC50 | 2800 | nM | IC50 | Eur J Med Chem (2018) 152: 570-589 [PMID:29763806] |
ChEMBL | Inhibition of recombinant human MAO-A assessed as reduction in 4-hydroxyquinoline formation using kynuramine as substrate after 20 mins by fluorometric assay | B | 5.61 | pIC50 | 2440 | nM | IC50 | J Nat Prod (2016) 79: 2538-2544 [PMID:27754693] |
ChEMBL | Inhibition of recombinant human MAO-A using kynuramine as substrate incubated for 10 mins followed by substrate addition and measured for 20 mins by Fluorescence microplate reader assay | B | 5.82 | pIC50 | 1520 | nM | IC50 | Eur J Med Chem (2020) 206: 112787-112787 [PMID:32942081] |
Monoamine oxidase A in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3254] [UniProtKB: P21398] | ||||||||
ChEMBL | Inhibition of bovine MAO-A by fluorimetric method | B | 8 | pIC50 | 10 | nM | IC50 | J Nat Prod (2006) 69: 945-949 [PMID:16792415] |
Monoamine oxidase B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2039] [GtoPdb: 2490] [UniProtKB: P27338] | ||||||||
ChEMBL | Inhibition of human MAOB | B | 4.05 | pIC50 | 90000 | nM | IC50 | Bioorg Med Chem (2010) 18: 1273-1279 [PMID:20045650] |
ChEMBL | Inhibition of MAO-B (unknown origin) | B | 4.05 | pIC50 | 90000 | nM | IC50 | Eur J Med Chem (2018) 152: 570-589 [PMID:29763806] |
ChEMBL | Inhibition of recombinant human MAO-B assessed as reduction in 4-hydroxyquinoline formation using kynuramine as substrate after 20 mins by fluorometric assay | B | 4.41 | pIC50 | 38660 | nM | IC50 | J Nat Prod (2016) 79: 2538-2544 [PMID:27754693] |
Monoamine oxidase B in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2756] [UniProtKB: P56560] | ||||||||
ChEMBL | Inhibition of bovine MAO-B by fluorimetric method | B | 4.7 | pIC50 | 20000 | nM | IC50 | J Nat Prod (2006) 69: 945-949 [PMID:16792415] |
Monocarboxylate transporter 1 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2073709] [GtoPdb: 988] [UniProtKB: P53987] | ||||||||
ChEMBL | TP_TRANSPORTER: inhibition of lactate uptake in Xenopus laevis oocytes | F | 4.85 | pIC50 | 14000 | nM | IC50 | Biochem J (1999) 341: 529-535 [PMID:10417314] |
Monocarboxylate transporter 2 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2073718] [GtoPdb: 990] [UniProtKB: Q63344] | ||||||||
ChEMBL | TP_TRANSPORTER: inhibition of lactate uptake in Xenopus laevis oocytes | F | 5.3 | pIC50 | 5000 | nM | IC50 | Biochem J (1999) 341: 529-535 [PMID:10417314] |
ABCC1/Multidrug resistance-associated protein 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3004] [GtoPdb: 779] [UniProtKB: P33527] | ||||||||
ChEMBL | TP_TRANSPORTER: inhibition of LTC4 uptake in membrane vesicle from MRP1-expressing HeLa cells | F | 5.09 | pKi | 8100 | nM | Ki | Mol Pharmacol (2001) 59: 1171-1180 [PMID:11306701] |
ChEMBL | Inhibition of MRP1 transfected in human HeLa cells assessed as inhibition of [3H]LTC4 transport by rapid filtration assay | B | 5.62 | pKi | 2400 | nM | Ki | J Med Chem (2009) 52: 5311-5322 [PMID:19725578] |
myeloperoxidase/Myeloperoxidase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2439] [GtoPdb: 2789] [UniProtKB: P05164] | ||||||||
ChEMBL | Inhibition of recombinant MPO (unknown origin) assessed as reduction in LDL oxidation in presence of H2O2 and HCl after 5 mins by ELISA | B | 5.51 | pIC50 | 3100 | nM | IC50 | J Med Chem (2017) 60: 6563-6586 [PMID:28671460] |
ChEMBL | Inhibition of myeloperoxidase | B | 5.9 | pIC50 | 1270 | nM | IC50 | J Med Chem (2012) 55: 7208-7218 [PMID:22793255] |
ChEMBL | Inhibition of MPO in human neutrophils using H2O2 as substrate measured after 1 hr by fluorescence based HPLC analysis | B | 5.9 | pIC50 | 1270 | nM | IC50 | Bioorg Med Chem Lett (2019) 29: 1-7 [PMID:30466896] |
ChEMBL | Inhibition of recombinant MPO (unknown origin) assessed as reduction in taurine chloramine production preincubated with enzyme and taurine followed by H2O2 addition measured after 5 mins | B | 5.94 | pIC50 | 1150 | nM | IC50 | J Med Chem (2017) 60: 6563-6586 [PMID:28671460] |
sirtuin 6/NAD-dependent protein deacetylase sirtuin-6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2163182] [GtoPdb: 2712] [UniProtKB: Q8N6T7] | ||||||||
ChEMBL | Inhibition of human SIRT6 using H3K9 myristoyl-peptide substrate | B | 5.72 | pIC50 | 1900 | nM | IC50 | J Med Chem (2021) 64: 9732-9758 [PMID:34213345] |
NADPH oxidase 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1250375] [GtoPdb: 3004] [UniProtKB: Q9NPH5] | ||||||||
ChEMBL | Inhibition of NOX4 expressed in HEK293 FS cells assessed as H2O2 production by H2O2/Tyr/LPO assay | B | 6.17 | pIC50 | 680 | nM | IC50 | J Med Chem (2010) 53: 6758-6762 [PMID:20731357] |
Neuraminidase in Influenza A virus (A/Puerto Rico/8/1934(H1N1)) (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2051] [UniProtKB: P03468] | ||||||||
ChEMBL | Inhibition of Influenza A PR/8/34 H1N1 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay | B | 1.25 | pIC50 | 1.25 | - | logIC50 | Eur J Med Chem (2010) 45: 1724-1730 [PMID:20116898] |
ChEMBL | Inhibition of Influenza A virus (H1N1) neuraminidase | B | 5.11 | pIC50 | 7750 | nM | IC50 | Bioorg Med Chem (2020) 28: 115191-115191 [PMID:31744778] |
Neuraminidase in Influenza A virus (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6135] [UniProtKB: B4URF0] | ||||||||
ChEMBL | Noncompetitive inhibition of recombinant influenza A virus rvH1N1 A/Bervig_Mission/1/18 neuraminidase | B | 5.42 | pKi | 3800 | nM | Ki | Bioorg Med Chem (2009) 17: 6816-6823 [PMID:19729316] |
ChEMBL | Inhibition of Influenza A Jinan/15/90 H3N2 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay | B | 4.06 | pIC50 | 87600 | nM | IC50 | Bioorg Med Chem (2008) 16: 7141-7147 [PMID:18640042] |
ChEMBL | Inhibition of Influenza A Jiangsu/10/2003 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay | B | 4.17 | pIC50 | 67500 | nM | IC50 | Bioorg Med Chem (2008) 16: 7141-7147 [PMID:18640042] |
ChEMBL | Inhibition of Influenza A PR/8/34 H1N1 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay | B | 4.23 | pIC50 | 58400 | nM | IC50 | Bioorg Med Chem (2008) 16: 7141-7147 [PMID:18640042] |
ChEMBL | Noncompetitive inhibition of recombinant influenza A virus rvH1N1 A/Bervig_Mission/1/18 neuraminidase | B | 5.66 | pIC50 | 2200 | nM | IC50 | Bioorg Med Chem (2009) 17: 6816-6823 [PMID:19729316] |
Inducible NOS/Nitric oxide synthase, inducible in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3464] [GtoPdb: 1250] [UniProtKB: P29477] | ||||||||
ChEMBL | Inhibition of iNOS-mediated nitric oxide production in LPS-stimulated mouse RAW264.7 cells after 24 hrs by Griess reaction analysis | B | 4.79 | pIC50 | 16400 | nM | IC50 | J Nat Prod (2013) 76: 489-494 [PMID:23517145] |
NUAK family kinase 1/NUAK family SNF1-like kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5784] [GtoPdb: 2129] [UniProtKB: O60285] | ||||||||
ChEMBL | Inhibition of ARK5 (unknown origin) | B | 5.29 | pIC50 | 5090 | nM | IC50 | J Nat Prod (2014) 77: 49-56 [PMID:24328302] |
pancreatic lipase/Pancreatic lipase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1812] [GtoPdb: 2590] [UniProtKB: P16233] | ||||||||
ChEMBL | Inhibition of pancreatic lipase (unknown origin) by spectrophotometeric analysis | B | 4.06 | pIC50 | 86980 | nM | IC50 | Bioorg Med Chem Lett (2024) 98: 129574-129574 [PMID:38052378] |
ChEMBL | Negative allosteric modulator activity at human Pancreatic lipase using DDAO-ol as fluorescent substrate preincubated for 3 mins followed by substrate addition measured after 20 mins by microplate reader assay | B | 5.82 | pIC50 | 1530 | nM | IC50 | Bioorg Med Chem (2023) 91: 117413-117413 [PMID:37490786] |
Pancreatic triacylglycerol lipase in Pig (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1687677] [UniProtKB: P00591] | ||||||||
ChEMBL | Inhibition of porcine pancreatic lipase using p-nitrophenylbutyrate as substrate assessed as formation of p-nitrophenol preincubated for 15 mins followed by substrate addition measured after 15 mins | B | 4.15 | pIC50 | >70000 | nM | IC50 | Bioorg Med Chem Lett (2015) 25: 2269-2274 [PMID:25935644] |
Peroxisome proliferator-activated receptor-γ/Peroxisome proliferator-activated receptor gamma in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL235] [GtoPdb: 595] [UniProtKB: P37231] | ||||||||
ChEMBL | Agonist activity at PPARgamma (unknown origin) | B | 4.59 | pIC50 | 26000 | nM | IC50 | Eur J Med Chem (2021) 221: 113535-113535 [PMID:33992930] |
ABCB1/P-glycoprotein 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4302] [GtoPdb: 768] [UniProtKB: P08183] | ||||||||
ChEMBL | Binding affinity to ABCB1 nucleotide binding domain 2 | B | 5.15 | pKd | 7079.46 | nM | Kd | Eur J Med Chem (2011) 46: 4078-4088 [PMID:21723648] |
ChEMBL | TP_TRANSPORTER: drug resistance (vincristine) in AML-2/D100 cells | F | 4.28 | pIC50 | 52500 | nM | IC50 | Biochem Biophys Res Commun (2004) 320: 672-679 [PMID:15240100] |
phosphodiesterase 2A/Phosphodiesterase 2A in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4650] [GtoPdb: 1297] [UniProtKB: Q01062] | ||||||||
ChEMBL | Inhibition of rat brain particulate cGMP phosphodiesterase | B | 4.09 | pIC50 | 81300 | nM | IC50 | J Med Chem (1982) 25: 1192-1198 [PMID:6292419] |
sPLA2-1B/Phospholipase A2 group 1B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4426] [GtoPdb: 1416] [UniProtKB: P04054] | ||||||||
ChEMBL | Inhibition of phospholipase A2 | B | 5.7 | pIC50 | 2000 | nM | IC50 | Proc Natl Acad Sci U S A (2007) 104: 20523-20528 [PMID:18077363] |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma/PI3-kinase p110-gamma subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3267] [GtoPdb: 2156] [UniProtKB: P48736] | ||||||||
ChEMBL | Inhibition of PI3Kgamma (unknown origin) assessed as decrease in fluorescence intensity using phosphorylated substrate | B | 4.86 | pIC50 | 13790 | nM | IC50 | Eur J Med Chem (2014) 84: 454-465 [PMID:25050878] |
phosphoinositide-3-kinase regulatory subunit 1/PI3-kinase p85-alpha subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2506] [GtoPdb: 2503] [UniProtKB: P27986] | ||||||||
ChEMBL | Inhibition of PI3K | B | 5.42 | pIC50 | 3800 | nM | IC50 | Proc Natl Acad Sci U S A (2007) 104: 20523-20528 [PMID:18077363] |
Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364] | ||||||||
ChEMBL | Antiplasmodial activity against asexual erythrocyte stage of chloroquine-sensitive Plasmodium falciparum 3D7 infected in human red blood cells after 48 hrs by lactate dehydrogenase assay | F | 4.76 | pIC50 | 17540 | nM | IC50 | J Nat Prod (2017) 80: 1750-1757 [PMID:28557449] |
ChEMBL | Antimalarial activity against chloroquine /mefloquine/pyrimethamine-resistant Plasmodium falciparum C235 by malaria SYBR green 1-based fluorescence (MSF) assay | F | 4.89 | pIC50 | 13000 | nM | IC50 | Bioorg Med Chem Lett (2015) 25: 327-332 [PMID:25488841] |
ChEMBL | Antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54 | F | 5 | pIC50 | 10000 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 4779-4781 [PMID:20637612] |
ChEMBL | Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum NF54 | F | 5 | pIC50 | 10000 | nM | IC50 | J Med Chem (2006) 49: 3345-3353 [PMID:16722653] |
ChEMBL | Antimalarial activity against chloroquine-sensitive/mefloquine-resistant Plasmodium falciparum D6 by malaria SYBR green 1-based fluorescence (MSF) assay | F | 5.05 | pIC50 | 9000 | nM | IC50 | Bioorg Med Chem Lett (2015) 25: 327-332 [PMID:25488841] |
ChEMBL | Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 | F | 5.05 | pIC50 | 8900 | nM | IC50 | J Med Chem (2006) 49: 3345-3353 [PMID:16722653] |
ChEMBL | Antimalarial activity against chloroquine-resistant/mefloquine-sensitive Plasmodium falciparum W2 by malaria SYBR green 1-based fluorescence (MSF) assay | F | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg Med Chem Lett (2015) 25: 327-332 [PMID:25488841] |
prolyl endopeptidase/Prolyl endopeptidase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3202] [GtoPdb: 2395] [UniProtKB: P48147] | ||||||||
ChEMBL | Inhibition of human brain prolyl oligopeptidase expressed in Escherichia coli | B | 4.89 | pIC50 | 13000 | nM | IC50 | Bioorg Med Chem (2008) 16: 7516-7524 [PMID:18650094] |
proteasome 20S subunit beta 5/Proteasome Macropain subunit MB1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4662] [GtoPdb: 2406] [UniProtKB: P28074] | ||||||||
ChEMBL | Inhibition of chymotrypsin-like activity of purified human 20S proteasome expressed in human Jurkat cells assessed as decrease in AMC hydrolysis using Suc-Leu-Leu-Val-Tyr-AMC as substrate incubated for 2 hrs by fluorescence based method | B | 5.46 | pIC50 | 3500 | nM | IC50 | Eur J Med Chem (2019) 167: 291-311 [PMID:30776692] |
ChEMBL | Inhibition of chymotrypsin-like activity of human 26S proteasome in human Jurkat cells assessed as decrease in AMC hydrolysis using Z-Gly-Gly-Leu-AMC as substrate after 24 hrs by fluorescence based method | B | 5.7 | pIC50 | 2000 | nM | IC50 | Eur J Med Chem (2019) 167: 291-311 [PMID:30776692] |
Protein E6 in Human papillomavirus type 16 (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2010633] [UniProtKB: P03126] | ||||||||
ChEMBL | Inhibition of GST-tagged Human papillomavirus 16 protein E6 interaction with His-tagged human caspase 8 expressed in Escherichia coli after 1 hr incubation followed by overnight incubation by Alpha screening technique | B | 4.7 | pIC50 | >20000 | nM | IC50 | Bioorg Med Chem Lett (2012) 22: 2125-2129 [PMID:22300659] |
protein kinase N1/Protein kinase N1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3384] [GtoPdb: 1520] [UniProtKB: Q16512] | ||||||||
ChEMBL | Inhibition of PRK1 (unknown origin) | B | 5.24 | pIC50 | 5800 | nM | IC50 | J Nat Prod (2014) 77: 49-56 [PMID:24328302] |
protein tyrosine phosphatase non-receptor type 1/Protein-tyrosine phosphatase 1B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL335] [GtoPdb: 2976] [UniProtKB: P18031] | ||||||||
ChEMBL | The inhibitory activity tested against human Protein-tyrosine phosphatase 1B enzyme | B | 4.63 | pIC50 | 23300 | nM | IC50 | Bioorg Med Chem Lett (2002) 12: 3387-3390 [PMID:12419367] |
ChEMBL | Inhibition of PTP1B | B | 4.63 | pIC50 | 23300 | nM | IC50 | Bioorg Med Chem (2009) 17: 2658-2672 [PMID:19297174] |
CoV Replicase polyprotein 1ab/CoV RNA-dependent RNA polymerase/CoV Non-structural protein 15/Replicase polyprotein 1ab in Severe acute respiratory syndrome-related coronavirus (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5118] [GtoPdb: 3125, 3139, 3206] [UniProtKB: P0C6X7] | ||||||||
ChEMBL | Inhibition of ATPase activity of SARS coronavirus helicase assessed as phosphate release by malachite green assay | B | 4.3 | pIC50 | >50000 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 4538-4541 [PMID:19625187] |
ChEMBL | Inhibition of SARS coronavirus 3C-like protease after 60 mins by FRET assay | B | 4.62 | pIC50 | 23800 | nM | IC50 | Bioorg Med Chem (2010) 18: 7940-7947 [PMID:20934345] |
ChEMBL | Inhibition of SARS coronavirus helicase assessed as duplex-DNA unwinding by FRET based assay | B | 5.09 | pIC50 | 8100 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 4538-4541 [PMID:19625187] |
CoV Replicase polyprotein 1ab/CoV RNA-dependent RNA polymerase/CoV Non-structural protein 15/CoV Non-structural protein 13/Replicase polyprotein 1ab in Severe acute respiratory syndrome coronavirus 2 (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4523582] [GtoPdb: 3125, 3139, 3206, 3261] [UniProtKB: P0DTD1] | ||||||||
ChEMBL | Inhibition of SARS-CoV-2 RdRp using ATP substrate preincubated with compound for 30 mins followed by substrate addition and measured after 30 mins by Alphascreen microplate reader analysis | B | 5.16 | pIC50 | 6900 | nM | IC50 | Bioorg Med Chem (2023) 80: 117179-117179 [PMID:36716583] |
Salivary alpha-amylase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2478] [UniProtKB: P0DUB6] | ||||||||
ChEMBL | Inhibition of human salivary alpha-amylase | B | 4.67 | pIC50 | 21400 | nM | IC50 | J Med Chem (2008) 51: 3555-3561 [PMID:18507367] |
Sarcoplasmic/endoplasmic reticulum calcium ATP-ase in Rabbit (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4693] [UniProtKB: P04191] | ||||||||
ChEMBL | Inhibition of rabbit skeletal muscle microsomes SERCA1a preincubated for 10 mins followed by addition of ATP and measured after 40 mins | B | 5.05 | pIC50 | 9000 | nM | IC50 | J Med Chem (2020) 63: 1937-1963 [PMID:32030976] |
AKT serine/threonine kinase 1/Serine/threonine-protein kinase AKT in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4282] [GtoPdb: 1479] [UniProtKB: P31749] | ||||||||
ChEMBL | Inhibition of AKT1 (unknown origin) | B | 5.27 | pIC50 | 5390 | nM | IC50 | J Nat Prod (2014) 77: 49-56 [PMID:24328302] |
aurora kinase B/Serine/threonine-protein kinase Aurora-B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2185] [GtoPdb: 1937] [UniProtKB: Q96GD4] | ||||||||
ChEMBL | Inhibition of aurora-B (unknown origin) | B | 6.04 | pIC50 | 910 | nM | IC50 | J Nat Prod (2014) 77: 49-56 [PMID:24328302] |
B-Raf proto-oncogene, serine/threonine kinase/Serine/threonine-protein kinase B-raf in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5145] [GtoPdb: 1943] [UniProtKB: P15056] | ||||||||
ChEMBL | Inhibition of B-Raf V600E mutant (unknown origin) using fluorescein-MAP2K1 as substrate after 1 hr by electrophoretic assay | B | 5.12 | pIC50 | 7589 | nM | IC50 | Medchemcomm (2017) 8: 1835-1844 [PMID:30108894] |
NIMA related kinase 2/Serine/threonine-protein kinase NEK2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3835] [GtoPdb: 2117] [UniProtKB: P51955] | ||||||||
ChEMBL | Inhibition of NEK2 (unknown origin) | B | 5.24 | pIC50 | 5730 | nM | IC50 | J Nat Prod (2014) 77: 49-56 [PMID:24328302] |
NIMA related kinase 6/Serine/threonine-protein kinase NEK6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4309] [GtoPdb: 2121] [UniProtKB: Q9HC98] | ||||||||
ChEMBL | Inhibition of NEK6 (unknown origin) | B | 5.37 | pIC50 | 4230 | nM | IC50 | J Nat Prod (2014) 77: 49-56 [PMID:24328302] |
Pim-1 proto-oncogene, serine/threonine kinase/Serine/threonine-protein kinase PIM1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2147] [GtoPdb: 2158] [UniProtKB: P11309] | ||||||||
ChEMBL | Binding affinity to non phosphorylated PIM1 | B | 7.6 | pKd | 25 | nM | Kd | J Med Chem (2005) 48: 7604-7614 [PMID:16302800] |
ChEMBL | Inhibition of PIM1 kinase | B | 0.04 | pIC50 | -0.04 | uM | -Log IC50 | Bioorg Med Chem (2007) 15: 6463-6473 [PMID:17637507] |
ChEMBL | Inhibition of Pim1 | B | 5.96 | pIC50 | 1100 | nM | IC50 | J Med Chem (2009) 52: 1814-1827 [PMID:19256503] |
ChEMBL | Competitive inhibition of PIM1 in presence of ATP | B | 5.96 | pIC50 | 1100 | nM | IC50 | J Med Chem (2012) 55: 8199-8208 [PMID:22924342] |
ChEMBL | Inhibition of PIM1 (unknown origin) | B | 6.3 | pIC50 | 500 | nM | IC50 | J Nat Prod (2014) 77: 49-56 [PMID:24328302] |
ChEMBL | Inhibitory activity against PIM1 | B | 7.37 | pIC50 | 43 | nM | IC50 | J Med Chem (2005) 48: 7604-7614 [PMID:16302800] |
polo like kinase 1/Serine/threonine-protein kinase PLK1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3024] [GtoPdb: 2168] [UniProtKB: P53350] | ||||||||
ChEMBL | Inhibition of PLK1 | B | 4.19 | pIC50 | 64000 | nM | IC50 | Bioorg Med Chem Lett (2008) 18: 4972-4977 [PMID:18762425] |
ChEMBL | Inhibition of PLK1 (unknown origin) | B | 5.24 | pIC50 | 5750 | nM | IC50 | J Nat Prod (2014) 77: 49-56 [PMID:24328302] |
5-HT1A receptor/Serotonin 1a (5-HT1a) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL214] [GtoPdb: 1] [UniProtKB: P08908] | ||||||||
ChEMBL | Displacement of [3H]8-OH-DPAT from human recombinant 5HT1A receptor expressed in CHO cells | B | 4 | pEC50 | >100000 | nM | EC50 | J Nat Prod (2006) 69: 432-435 [PMID:16562853] |
TRPC5/Short transient receptor potential channel 5 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1250411] [GtoPdb: 490] [UniProtKB: Q9UL62] | ||||||||
ChEMBL | Inhibition of human TRPC5 expressed in HEK293 cells assessed as reduction in gadolinium-induced calcium entry after 30 mins by fluo-4 dye based fluorescence assay | B | 5.19 | pIC50 | 6500 | nM | IC50 | J Med Chem (2019) 62: 7589-7602 [PMID:30943030] |
Sialidase in Clostridium perfringens (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5189] [UniProtKB: P10481] | ||||||||
ChEMBL | Inhibition of Clostridium perfringens neuraminidase assessed as inhibition of 4-MU-NANA hydrolysis after 10 mins by spectrofluorimetry | B | 4.6 | pIC50 | 25340 | nM | IC50 | Bioorg Med Chem (2010) 18: 3335-3344 [PMID:20363636] |
ChEMBL | Inhibition of Clostridium perfringens neuraminidase using 4-methylumbelliferyl-alpha-D-N-acetylneuraminic acid as substrate by fluorimetry | B | 5 | pIC50 | 10060 | nM | IC50 | Bioorg Med Chem Lett (2011) 21: 6100-6103 [PMID:21911291] |
ChEMBL | Inhibition of Clostridium perfringens neuraminidase by fluorimetry | B | 5.01 | pIC50 | 9800 | nM | IC50 | Bioorg Med Chem (2010) 18: 6258-6264 [PMID:20696581] |
ChEMBL | Inhibition of Clostridium perfringens neuraminidase by fluorimetry | B | 5.57 | pIC50 | 2700 | nM | IC50 | Bioorg Med Chem (2009) 17: 2744-2750 [PMID:19285413] |
ChEMBL | Inhibition of Clostridium perfringens neuraminidase | B | 5.77 | pIC50 | 1700 | nM | IC50 | Bioorg Med Chem (2009) 17: 6816-6823 [PMID:19729316] |
Glucose transporter 2/Solute carrier family 2, facilitated glucose transporter member 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5873] [GtoPdb: 876] [UniProtKB: P11168] | ||||||||
ChEMBL | Inhibition of human GLUT2 expressed in Xenopus laevis oocytes assessed as reduction in [14C]fructose uptake by scintillation spectrometric method | B | 4.92 | pIC50 | 12000 | nM | IC50 | Medchemcomm (2016) 7: 1716-1729 [PMID:28042452] |
ChEMBL | Inhibition of human GLUT2 expressed in Xenopus laevis oocytes assessed as reduction in [3H] 2-deoxyglucose uptake by scintillation spectrometric method | B | 4.92 | pIC50 | 12000 | nM | IC50 | Medchemcomm (2016) 7: 1716-1729 [PMID:28042452] |
Glucose transporter 4/Solute carrier family 2, facilitated glucose transporter member 4 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3286066] [GtoPdb: 878] [UniProtKB: P19357] | ||||||||
ChEMBL | Competitive inhibition of GLUT4 in Wistar rat adipocytes assessed as reduction in insulin-stimulated 3-O-[3H]methyl-D-glucose uptake measured for 30 secs by Lineweaver-Burk plot analysis | B | 4.8 | pKi | 16000 | nM | Ki | Medchemcomm (2016) 7: 1716-1729 [PMID:28042452] |
OATP2B1/Solute carrier organic anion transporter family member 2B1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1743124] [GtoPdb: 1224] [UniProtKB: O94956] | ||||||||
ChEMBL | Inhibition of human OATP2B1 expressed in Flp-In-CHO cells assessed as inhibition of OATP2B1 mediated DBF uptake using DBF as fluorescent substrate incubated for 2 mins by BCA assay | B | 5.14 | pIC50 | 7300 | nM | IC50 | RSC Med Chem (2023) 14: 890-898 [PMID:37252098] |
ChEMBL | Inhibition of human OATP2B1 expressed in Flp-In-CHO cells assessed as inhibition of OATP2B1 mediated DBF uptake using DBF as fluorescent substrate incubated for 2 mins by BCA assay | B | 5.14 | pIC50 | 7244.36 | nM | IC50 | RSC Med Chem (2023) 14: 890-898 [PMID:37252098] |
Sorbitol dehydrogenase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2275] [UniProtKB: Q00796] | ||||||||
ChEMBL | In vitro inhibitory activity against sorbitol dehydrogenase (SD) from sheep liver | B | 4.45 | pIC50 | 35600 | nM | IC50 | J Med Chem (2003) 46: 1419-1428 [PMID:12672241] |
Sortase A in S.aureus (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5362] [UniProtKB: Q9S446] | ||||||||
ChEMBL | Inhibition of recombinant Staphylococcus aureus ATCC 6538p SrtA expressed in Escherichia coli TOP10 using Dabcyl-QALPETGEE-Edans as substrate incubated for 1 hr by fluorometric analysis | B | 4.28 | pIC50 | 52700 | nM | IC50 | J Med Chem (2021) 64: 13097-13130 [PMID:34516107] |
sphingosine kinase 1/Sphingosine kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4394] [GtoPdb: 2204] [UniProtKB: Q9NYA1] | ||||||||
ChEMBL | Inhibition of SphK1 (unknown origin) expressed in Escherichia coli BL21 (DE3) using ATP as substrate preincubated for 60 mins followed by substrate addition and measured after 30 mins by malachite green-based microtitre-plate assay | B | 5.55 | pIC50 | 2800 | nM | IC50 | Eur J Med Chem (2021) 213: 113164-113164 [PMID:33454547] |
CoV Spike glycoprotein/Spike glycoprotein in Severe acute respiratory syndrome coronavirus 2 (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4662936] [GtoPdb: 3114] [UniProtKB: P0DTC2] | ||||||||
ChEMBL | Inhibition of SARS-COV2 spike protein mediated infection of human ACE2 expressing cells at 50 uM by SPR analysis | B | 4.08 | pIC50 | 83400 | nM | IC50 | J Med Chem (2020) 63: 12256-12274 [PMID:32539378] |
coagulation factor II, thrombin/Thrombin in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL204] [GtoPdb: 2362] [UniProtKB: P00734] | ||||||||
ChEMBL | Inhibition of human thrombin assessed as equilibrium dissociation constant at 50 to 1000 uM by BIAcore analysis | B | 7.41 | pKd | 38.7 | nM | Kd | Med Chem Res (2013) null: 1-14 [PMID:24610996] |
ChEMBL | Inhibition of thrombin (unknown origin) assessed as hydrolysis of N-benzoyl-phenylalanylvalyl-arginine-paranitroanilide | B | 4.52 | pIC50 | 30000 | nM | IC50 | Med Chem Res (2013) null: 1-14 [PMID:24610996] |
ChEMBL | Inhibition of human thrombin amidolytic activity using D-Phe-Pip-Arg-pNA as substrate preincubated for 10 mins followed by substrate addition measured every 12 secs for 10 mins by spectrophotometric analysis | B | 5.82 | pIC50 | 1500 | nM | IC50 | Med Chem Res (2013) null: 1-14 [PMID:24610996] |
Trypsin I in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3769] [UniProtKB: P00760] | ||||||||
ChEMBL | Inhibitory concentration of the compounds against Bovine trypsin enzyme. | B | 5.15 | pIC50 | 7100 | nM | IC50 | J Med Chem (1997) 40: 4136-4145 [PMID:9406602] |
Tyrosinase in Agaricus bisporus (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3318] [UniProtKB: O42713] | ||||||||
ChEMBL | Inhibition of mushroom tyrosinase | B | 4.51 | pIC50 | 31000 | nM | IC50 | Bioorg Med Chem (2010) 18: 2337-2345 [PMID:20189399] |
tyrosinase/Tyrosinase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1973] [GtoPdb: 2643] [UniProtKB: P14679] | ||||||||
ChEMBL | Inhibition of tyrosinase (unknown origin) | B | 4.35 | pIC50 | 44380 | nM | IC50 | Bioorg Med Chem Lett (2022) 65: 128722-128722 [PMID:35395370] |
LCK proto-oncogene, Src family tyrosine kinase/Tyrosine-protein kinase LCK in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL258] [GtoPdb: 2053] [UniProtKB: P06239] | ||||||||
ChEMBL | Ability to inhibit protein-tyrosine kinase activity of p56lck (isolated from bovine thymus) in vitro. | B | 4.89 | pIC50 | 13000 | nM | IC50 | J Med Chem (1991) 34: 798-806 [PMID:1995903] |
ChEMBL | Inhibition of LCK | B | 4.89 | pIC50 | 13000 | nM | IC50 | J Nat Prod (2006) 69: 14-17 [PMID:16441060] |
fms related receptor tyrosine kinase 3/Tyrosine-protein kinase receptor FLT3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1974] [GtoPdb: 1807] [UniProtKB: P36888] | ||||||||
ChEMBL | Inhibition of recombinant FLT3 (unknown origin) by TR-FRET assay | B | 6.23 | pIC50 | 590 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 1768-1770 [PMID:23411073] |
ret proto-oncogene/Tyrosine-protein kinase receptor RET in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2041] [GtoPdb: 2185] [UniProtKB: P07949] | ||||||||
ChEMBL | Inhibition of wild type recombinant human RET using peptide as substrate by fluorimetric analysis | B | 4.11 | pIC50 | 78100 | nM | IC50 | Eur J Med Chem (2018) 150: 491-505 [PMID:29549836] |
AXL receptor tyrosine kinase/Tyrosine-protein kinase receptor UFO in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4895] [GtoPdb: 1835] [UniProtKB: P30530] | ||||||||
ChEMBL | Inhibition of AXL (unknown origin) | B | 6.02 | pIC50 | 960 | nM | IC50 | J Nat Prod (2014) 77: 49-56 [PMID:24328302] |
SRC proto-oncogene, non-receptor tyrosine kinase/Tyrosine-protein kinase SRC in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL267] [GtoPdb: 2206] [UniProtKB: P12931] | ||||||||
ChEMBL | Inhibition of Src | B | 4.82 | pIC50 | 15000 | nM | IC50 | Eur J Med Chem (2009) 44: 1982-1988 [PMID:19041163] |
ChEMBL | Inhibition of SRC (unknown origin) | B | 6.92 | pIC50 | 120 | nM | IC50 | J Nat Prod (2014) 77: 49-56 [PMID:24328302] |
spleen associated tyrosine kinase/Tyrosine-protein kinase SYK in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2599] [GtoPdb: 2230] [UniProtKB: P43405] | ||||||||
ChEMBL | Inhibition of SYK | B | 4.7 | pIC50 | 20000 | nM | IC50 | J Med Chem (2012) 55: 3614-3643 [PMID:22257213] |
ChEMBL | Inhibition of SYK in human mast cells assessed as reduction in mast cell degranulation | B | 4.46 | pEC50 | 35000 | nM | EC50 | J Med Chem (2012) 55: 3614-3643 [PMID:22257213] |
YES proto-oncogene 1, Src family tyrosine kinase/Tyrosine-protein kinase YES in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2073] [GtoPdb: 2284] [UniProtKB: P07947] | ||||||||
ChEMBL | Inhibition of YES (unknown origin) | B | 6.33 | pKi | 472 | nM | Ki | Eur J Med Chem (2019) 166: 186-196 [PMID:30769179] |
Urease subunit alpha/Urease subunit beta in Helicobacter pylori (strain ATCC 700392 / 26695) (Campylobacterpylori) (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL3885651] [UniProtKB: P14916, P69996] | ||||||||
ChEMBL | Inhibition of Helicobacter pylori urease assessed as measuring ammonia production incubated for 1.5 hr by indophenol method | B | 5.03 | pKi | 9340 | nM | Ki | Eur J Med Chem (2022) 229: 114068-114068 [PMID:34971873] |
ChEMBL | Inhibition of Helicobacter pylori urease | B | 4.95 | pIC50 | 11200 | nM | IC50 | Eur J Med Chem (2013) 68: 212-221 [PMID:23974021] |
ChEMBL | Inhibition of Helicobacter pylori urease assessed as measuring ammonia production incubated for 1.5 hr by indophenol method | B | 4.95 | pIC50 | 11200 | nM | IC50 | Eur J Med Chem (2022) 229: 114068-114068 [PMID:34971873] |
ChEMBL | Inhibition of Helicobacter pylori ATCC 43504 urease-mediated ammonia production preincubated for 1.5 hrs by indophenol method | B | 4.96 | pIC50 | 11000 | nM | IC50 | Eur J Med Chem (2013) 63: 685-695 [PMID:23567958] |
plasminogen activator, urokinase/Urokinase-type plasminogen activator in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3286] [GtoPdb: 2393] [UniProtKB: P00749] | ||||||||
ChEMBL | Inhibition of urokinase amidolytic activity (unknown origin) | B | 4.92 | pIC50 | 12100 | nM | IC50 | Med Chem Res (2013) null: 1-14 [PMID:24610996] |
kinase insert domain receptor/Vascular endothelial growth factor receptor 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL279] [GtoPdb: 1813] [UniProtKB: P35968] | ||||||||
ChEMBL | Inhibition of recombinant human VEGFR2 using peptide as substrate by fluorimetric analysis | B | 5.78 | pIC50 | 1660 | nM | IC50 | Eur J Med Chem (2018) 150: 491-505 [PMID:29549836] |
ChEMBL | Inhibition of VEGFR2 (unknown origin) | B | 6.55 | pIC50 | 280 | nM | IC50 | J Nat Prod (2014) 77: 49-56 [PMID:24328302] |
V2 receptor/Vasopressin V2 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1790] [GtoPdb: 368] [UniProtKB: P30518] | ||||||||
ChEMBL | Inhibition of vasopressin-stimulated vasopressin V2 receptor in human HTLA cells pre-incubated for 20 mins with centrifuged compound solution measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay | B | 4.4 | pIC50 | 39810.72 | nM | IC50 | J Med Chem (2013) 56: 2406-2414 [PMID:23437772] |
ChEMBL | Inhibition of vasopressin-stimulated vasopressin V2 receptor in human HTLA cells pre-incubated for 20 mins with centrifuged compound solution measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay | B | 4.42 | pIC50 | 37800 | nM | IC50 | J Med Chem (2013) 56: 2406-2414 [PMID:23437772] |
ChEMBL | Inhibition of vasopressin-stimulated vasopressin V2 receptor in human HTLA cells pre-incubated for 20 mins with Tween-80-treated compound solution measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay | B | 4.8 | pIC50 | 15848.93 | nM | IC50 | J Med Chem (2013) 56: 2406-2414 [PMID:23437772] |
ChEMBL | Inhibition of vasopressin-stimulated vasopressin V2 receptor in human HTLA cells pre-incubated for 20 mins with Tween-80-treated compound solution measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay | B | 4.82 | pIC50 | 15200 | nM | IC50 | J Med Chem (2013) 56: 2406-2414 [PMID:23437772] |
ChEMBL | Inhibition of vasopressin-stimulated vasopressin V2 receptor in human HTLA cells pre-incubated for 20 mins measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay | B | 5.15 | pIC50 | 7000 | nM | IC50 | J Med Chem (2013) 56: 2406-2414 [PMID:23437772] |
ChEMBL | Inhibition of vasopressin-stimulated vasopressin V2 receptor in human HTLA cells pre-incubated for 20 mins measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay | B | 5.2 | pIC50 | 6309.57 | nM | IC50 | J Med Chem (2013) 56: 2406-2414 [PMID:23437772] |
xanthine dehydrogenase/Xanthine dehydrogenase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1929] [GtoPdb: 2646] [UniProtKB: P47989] | ||||||||
ChEMBL | Inhibition of xanthine oxidase (unknown origin) at 37 degC at ph 7..8 | B | 6.55 | pKi | 280 | nM | Ki | J Nat Prod (2014) 77: 1693-1699 [PMID:25060641] |
ChEMBL | Inhibition of xanthine oxidase (unknown origin) using xanthine as substrate assessed as inhibition of uric acid formation after 30 mins by spectrophotometric method | B | 5.46 | pIC50 | 3500 | nM | IC50 | Eur J Med Chem (2016) 119: 197-217 [PMID:27162124] |
ChEMBL | Inhibition of xanthine oxidase-mediated formation of uric acid by spectrophotometry | B | 5.52 | pIC50 | 3000 | nM | IC50 | J Nat Prod (2002) 65: 1526-1529 [PMID:12444671] |
ChEMBL | Inhibition of xanthine oxidase assessed as decrease in uric acid production by spectrophotometry | B | 5.58 | pIC50 | 2620 | nM | IC50 | J Nat Prod (1998) 61: 71-76 [PMID:9461655] |
ChEMBL | Inhibition of XO (unknown origin) | B | 6.4 | pIC50 | 400 | nM | IC50 | J Med Chem (2023) 66: 14474-14493 [PMID:37908076] |
Xanthine dehydrogenase in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3649] [UniProtKB: P80457] | ||||||||
ChEMBL | Inhibition of bovine xanthine oxidase | B | 5.92 | pKi | 1200 | nM | Ki | J Nat Prod (2009) 72: 725-731 [PMID:19388706] |
ChEMBL | Inhibition of bovine milk xanthine oxidase assessed using xanthine as substrate after 10 mins by fluorometric assay | B | 4.5 | pIC50 | 31900 | nM | IC50 | Eur J Med Chem (2017) 135: 491-516 [PMID:28478180] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]